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INTRODUCTION 
 Cancer of the larynx is the second most common malignancy of the upper aerodigestive 
tract (UADT).  Even though large varieties of malignancies are reported in the larynx, 90%
1, 2
 of 
them are Squamous Cell Carcinoma (SCC) which arises from the epithelial lining of the larynx.  
The most common site of laryngeal carcinoma is the glottis
3
. 
 About 90% of malignant tumors of the larynx are carcinomas that often develop from 
premalignant lesions
4
. Therefore, early detection and prompt treatment should thus prevent the 
development of invasive cancer requiring more debilitating surgical resection
5
. It is very difficult 
to predict accurately which lesions will progress to invasive malignancy based only on clinical 
appearance. 
 Studies have proven that the clinical appearance bears little correlation with the 
underlying pathology. What makes decision making difficult is that simple hyperplasia, 
dysplasia, and or carcinoma can all coexist in same lesion. Even, stroboscopy has not proved to 
be reliable method of determining the presence of malignancy or depth of invasion.  At present 
there is no standard test to identify benign lesions from premalignant or malignant ones. 
 Many attempts have been done to differentiate a premalignant from a malignant lesion 
intra operatively. This includes the application of vital dyes like toluidine blue and methylene 
blue, contact endoscopy, induced autofluorescence using 5-ALA ( 5-aminolevulinic acid ), 
compact endoscopy (ie combined use of autofluorescence and contact endoscopy) and Optical 
2 
 
Coherence Tomography (OCT).  But the wide spread use of these techniques were limited by 
cost factors and limited sensitivity and specificity. 
 In this study a novel approach has been tried for differentiating benign, pre malignant and 
malignant lesions in the vocal cords, intra operatively by using the vital dye Lugol’s iodine, 
which is widely used in the oral cavity for the same purpose
6
.  Lugol’s iodine has also been used 
in oesophagoscopy as safe, inexpensive, simple and rapid to perform, easy to interpret and highly 
sensitive adjuvant for all clinically important squamous neoplasia. Evidence shows that visual 
inspection methods using Lugol's iodine has more sensitivity, visual inspection allows an 
immediate result and, when appropriate, may be immediately followed by therapy, the so called 
"screen-and-treat" approach
7
. Its effectiveness as a screening strategy to decrease cervical cancer 
mortality and to increase life years is also well studied. Hence Lugol’s iodine is a good choice as 
a visual staining agent to identify/exclude cancerous and precancerous lesions in resource-
constrained region
8
. This same principle is being applied in the detection of pre malignant and 
malignant lesions of the glottis region. 
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AIMS & OBJECTIVES 
 
Objective 
 To evaluate a commonly available, easily applicable and cost effective method to 
diagnose the presence of pre malignant and malignant vocal cord neoplasm. 
 
Aim 
1. To observe the staining property of Lugol’s iodine in various vocal cord lesions. 
 
2. To assess the reliability of Lugol’s iodine in the evaluation of pre malignant and malignant vocal 
cord lesions. 
The hypothesis is that Lugol’s iodine “stains” normal epithelium and benign lesions where as 
 pre malignant and malignant lesions remain unstained. 
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REVIEW OF LITERATURE 
 
             Cancer of the larynx is the second most common malignancy of the upper aerodigestive 
tract (UADT)
1
.  This accounts for approximately 1.7% of all new cancer diagnosis, 25% of all 
head and neck malignancies and in 90% of cases it is squamous cell carcinoma
2
.  
 In India, laryngeal carcinoma constitutes 2.63% of all body cancers, ten times more 
common in males than females (4.79% vs 0.47%) with an incidence of 3.29 new cases in males 
and 0.42 new cases in females for one lakh population
9
. There seems to be a tendency to be 
mainly a disease of the middle aged men with a peak incidence in the seventh decade. Women 
are affected in a comparatively younger age with a peak incidence at less than sixty years
10
.  
Although a large variety of malignancies are reported in the larynx, 85-95 percentage of   
laryngeal malignancies are squamous cell carcinoma (SCC), arising from the epithelial lining of 
the larynx
11
. Classically laryngeal carcinoma is divided by sub sites into supra glottic, glottic and 
sub glottic cancers. The most common site for laryngeal squamous cell carcinoma is the glottic 
larynx
3
. 
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Fig. 1 Distribution of laryngeal squamous cell carcinoma
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Aetiology of laryngeal carcinoma 
           Smoking, alcohol, chemical exposure, laryngopharyngeal reflux, viral etiology and diet 
are considered as the risk factors for laryngeal cancer.  Squamous cell carcinoma of the larynx is 
strongly associated with the use of tobacco and alcohol. They are the two strongest aetiological 
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factors for the development of Head and Neck Squamous Cell Carcinoma (HNSCC), both 
independently and synergistically
12, 13.
  Tobacco has been identified as the main causative agent 
in laryngeal cancer, with up to 98% of patients being smokers
14
. In non smokers, alcohol may 
increase the relative risk of laryngeal carcinoma by five fold.  
Nickel and chromate refining workers have an increased incidence of laryngeal squamous 
cell carcinoma
15
. Chronic laryngeal inflammation caused by acid reflux may be a carcinogenic 
co factor similar to Barrett’s oesophagus.  Gastric acid reflux has been established as a risk factor 
for laryngeal carcinoma.  Recently alkaline reflux has been identified as a laryngeal carcinogen 
by Gilli and colleagues
16
. They identified a higher number of patients with laryngo pharyngeal 
cancer associated with achlorhydria and presumed alkaline reflux after gastric resection. They 
also identified that, in patients with laryngeal carcinoma with an intact gastric acid secreting 
mechanism, 81% showed abnormal acid reflux on 24 hour pH monitoring
16
.  Human Papilloma 
Virus (HPV)   subtypes 16 and 18 found to be closely related to laryngeal carcinoma and it is 
identified in 40% of cases
17
. HPV is an independent risk factor for laryngeal carcinoma. Poor 
nutritional status is associated with increased relative risk of laryngeal carcinoma. Fruits and 
vegetables are found to have a protective effect, which may be attributed to their high Vitamin A 
and Vitamin C content
18
. 
 The multiple aetiological factors act on the various levels of the molecular structure of 
the epithelial cell lining of larynx and act as carcinogens.  So a series of events occur and there is 
a progression of normal mucosa to pre malignant lesions and then to invasive disease
19
. 
 
7 
 
 
Progression of normal epithelium to pre malignant and to invasive disease in Squamous 
Cell Carcinoma.
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Anatomy, Embryology and Histology of vocal cords 
 
 
Fig.2  Anatomy & Subdivisions of the larynx 
Embryology 
  The larynx is divided into three regions or sites: supra glottis, glottis and sub glottis. This 
division reflects the embryologic structure of the larynx and the anatomical barriers to spread of 
laryngeal cancer. The pattern of spread of tumours within the larynx is guided by the ligaments, 
connective tissue membranes, cartilages of the larynx that contain the spread of tumour, as well 
as by the soft tissue spaces within the larynx, that act as pathways within and outside of the 
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larynx. The characteristic tumour pattern can be explained by the embryologic development of 
the larynx. The supra glottis is derived from the buccopharyngeal primordium, which develops 
from the third and fourth branchial arches. The glottis and sub glottis are developed from the 
tracheobronchial primordium. Due to this reason the larynx has a dual blood supply and 
lymphatic drainage. The supra glottis is supplied by the superior laryngeal arteries and its 
lymphatic drainage follow these vessels into the carotid sheath into the deep cervical nodes in 
level 2 and level 3.  The glottis and sub glottis are supplied by the inferior laryngeal arteries, and 
lymphatic drainage from these regions follow these arteries to drain into pre laryngeal and pre 
tracheal nodes, and finally drains into deep cervical nodes in level 4 
20
.  The glottic region is 
formed by the paired structures that fuse in the midline. So the lymphatics drain unilaterally. The 
vocal folds have sparse lymphatics. This explains the lower incidence of lymphatic metastasis in 
glottis squamous cell carcinoma. But the supra glottis is formed without a midline union, its 
lymphatics drain bilaterally and this causes the increased likelihood of bilateral lymphatic 
metastasis from supra glottic carcinoma
21, 22
. 
Anatomy 
 The larynx is divided systematically into supra glottis, glottis and sub glottis.  This 
division reflects the embryologic structure and the anatomic barriers to spread of laryngeal 
cancer.  The supra glottis is composed of the supra hyoid and infra hyoid epiglottis (both the 
lingual and the laryngeal surfaces), aryepiglottic folds (laryngeal surface only), arytenoids and 
the ventricular bands (false cords)
23
. The inferior limit of supra glottis is a horizontal plane 
through the lateral margin of the ventricle at its junction with the superior surface of the true 
vocal cords. The glottis consists of bilateral true vocal cords including the anterior and posterior 
10 
 
commissures. The inferior surface of the glottis is a horizontal plane 1cm inferior to the inferior 
limit of the supraglottis 
23. 
The sub glottis extends from the inferior limit of the glottis to the 
inferior edge of the cricoid cartilage. Subglottis is not divided into any further subsites
23
. 
Histology 
 The mucosal lining of the larynx differs in the three regions. The epithelium of the supra 
glottis is predominantly of the pseudo stratified columnar type, except at the edges of the 
aryepiglottic folds and the lateral borders of the epiglottis, which is stratified squamous 
epithelium. The true vocal cords have a unique structure: non keratinized stratified squamous 
epithelium, which covers a three layered lamina propria. The lamina propria is composed of 
superficial, intermediate and deep layers. The intermediate and deep layers of lamina propria 
form the vocal ligament. The subglottis is lined by pseudo stratified columnar epithelium
24
. 
 
Fig.3   Histology of the vocal cords. 
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Clinical evaluation of Suspected Vocal Cord Pathology: 
 
        History and Presenting Complaints: Hoarseness is a non specific symptom that can 
result from a variety of disease processes ranging from a benign polyp to potentially life 
threatening carcinoma. It can also be a manifestation of systemic disease that can affect the 
larynx. Any patient with hoarseness of more than two weeks should undergo a proper vocal cord 
assessment. A proper evaluation includes a thorough history, physical examination and vocal 
cord visualisation including indirect laryngoscopic examination and endoscopic assessment of 
vocal cords. 
       Obtaining an accurate history is of utmost importance, hence a detailed history about 
onset, duration, and severity of dysphonia should be enquired.  Other symptoms like stridor, 
dyspnoea, dysphagia, odynophagia etc should be noted. History of voice abuse and risk factors 
like smoking and alcohol intake is essential. Past history of any laryngeal surgeries and systemic 
illness is to be recorded. 
 Clinical Examination: As with any oto-laryngological examination, a complete head and neck 
examination is essential especially to evaluate the neck nodes. The indirect mirror exam is the 
initial procedure used to visualize the larynx. It is quick, inexpensive and only requires only a 
mirror and external light source. In this gross abnormalities may be detected quickly, but minor 
lesion may be missed.    
 
12 
 
 
 
Fig.4 Appearance of larynx on indirect laryngoscopic examination 
 
        Rigid laryngeal endoscopy is performed using 70 or 90 degree endoscopes passing 
through the mouth to obtain images of the larynx and pharynx.  These are the highest quality 
images obtainable and offer excellent magnification. 
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Fig.5 Fibrolaryngoscopy picture of the vocal cords 
 
 
  Grabas CS et al
25
 in their study on the relevance of mirror examination on larynx 
commented that 84% of the indirect laryngoscopies could be used to give a reasonable 
examination of the larynx, but it is not adequate, and fibrolaryngoscopy is a good alternative and 
a more reliable examination. Disadvantages include the larynx not being in physiologic 
phonation position, hyper reflexive gag, uncooperative patient and nonvisualisation of hidden 
areas of larynx like subglottis, ventricles, laryngeal surface of epiglottis etc.  In a study by Barker 
et al 
26
 the diagnostic accuracy and examination, the success rates of indirect 
laryngoscopy versus a rigid rod examination were assessed and compared.  52% of mirror 
examinations were successful as were 83% of rod exams. They conclude that the mirror is a 
14 
 
useful screening tool so long as strict examination criteria are used. The rigid rod endoscopy 
adds further diagnostic information in those patients who cannot be evaluated with a mirror.  
 
 
 The flexible laryngoscope is probably the instrument that most otolaryngologists use in 
the evaluation of the dysphonic patient.  It is the only method that allows examination of the 
nasopharynx, palate, larynx, and pharynx in a near physiologic position.  It can be performed 
relatively easily in patients with hyper-responsive gags and pediatric patients. This is the most 
commonly used office procedure for the evaluation of vocal cord pathology. 
 
 Videostrobolaryngoscopy (VSL) allows for dynamic assessment of the vocal folds.  The 
features most helpful in the diagnostic process include the vocal fold closure pattern, vocal fold 
vibratory pattern, and the mucosal wave of each vocal fold during phonation. It is an excellent 
tool in the assessment of vocal cord mobility, mucosal wave pattern and detecting early lesions 
of the vocal cords. 
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Fig.6 Stroboscopic images showing vocal fold vibratory pattern and the mucosal wave 
  
Benign lesions of the vocal cord  
 Benign vocal cord lesions are non cancerous growths of abnormal tissue in the vocal 
folds. They are commonly referred to as Benign Vocal Fold Lesions (BVFLs), according to the 
new nomenclature system, proposed by Clark A Rosen et al 
27
.  According to this classification, 
nine distinct vocal fold lesions are mentioned. 
1. Vocal fold nodules. 
2. Vocal fold polyps 
3. Pseudocysts 
16 
 
4. Vocal fold cysts- subepithelial 
5. Vocal fold cysts- ligamental 
6. Non specific vocal fold lesions (NSVFL) 
7. Vocal fold fibrous mass- subepithelial 
8. Vocal fold fibrous mass- ligamental 
9. Reactive vocal fold lesions. 
 
   Various factors have been attributed to the aetiology of benign vocal cold lesions. The 
most important of which is chronic voice abuse. Others are acute vocal misuse, trauma resulting 
from infection and inflammation caused by Gastro Esophageal Reflux Disease (GERD).  The 
other factors which contribute to the chronic irritation of the larynx include post nasal drip 
caused by allergic rhinitis or chronic sinusitis, exposure to chemical irritants such as that from 
tobacco or substance abuse, pulmonary disease which may lead to poor breath support during 
speech, cough variant asthma, poor vocal hygiene and systemic diseases like hypothyroidism. 
Various benign vocal fold lesions (BVFL) include 
 
Vocal fold polyps:  A true focal fold polyp is a benign swelling of greater than 3mm that arises 
from the free edge of the vocal fold
28
.  It is usually solitary, but can rarely affect both vocal cords 
and can be pedunculated or sessile. It is known that polyps are the most common lesion of the 
vocal cord that causes hoarseness. It affects men more than women and most commonly seen in 
smokers between the age of 30 to 50 years 
29, 30
. Phono trauma is the most common cause for 
polyp formation. Vocal fold polyp is exophytic and often translucent or haemorrhagic. The 
17 
 
overlying mucosa is usually thin and atrophic. Histology shows a gelatinous substance without 
encapsulation within the stratified squamous epithelium 
25
. Most polyps do not resolve or 
become smaller with voice rest or voice therapy and they need excision under general 
anaesthesia. 
 
 
Fig.7  Polyp of the right vocal cord. 
 
Vocal fold nodules: Vocal nodules are bilateral small swellings (less than 3mm in diameter) that 
develop on the free edge of the vocal fold at the mid membranous portion. The aetiology of voice 
abuse is traditionally believed to be voice abuse. Vocal fold nodules are characterised 
histologically by thickening of the epithelium and underlying inflammation 
27
. This may be 
associated with microwebs in the anterior commissure in some cases. Its incidence is found to be 
25% in children
31
 and is 6% in adults with persistent hoarseness of voice. But higher percentage 
18 
 
is found in teachers and singers
32
. In children, they are most common in boys, than girls, but in 
adults it is most common in young ladies especially below the age of 30 years 
27
. A key 
stroboscopic feature for vocal nodule is normal or minimal impairment of the vibratory 
properties of the mucosa 
25
. A focal nodule respond well to voice therapy and voice rest and 
these lesions are usually treated non operatively 
25
. 
 
  
 
Fig.8  Bilateral Vocal cord nodules 
Pseudocyst:  It is a sub epithelial lesion associated with chronic glottal incompetence, eg: vocal 
scar, paresis or paralysis. It is usually unilateral. The lesion is very superficial in nature. The 
lesion is very clear with blister appearance that contains a semisolid fluid underneath thinned 
epithelium without encapsulation 
25
. The vibratory properties of the vocal fold mucosa are 
19 
 
normal or minimally reduced.  Pseudo cyst does not respond to conservative therapy.  The 
treatment is surgical removal with correction of underlying glottal incompetence. 
Vocal fold cysts:  Vocal fold cysts (VFC) may be within the sub epithelium or in the ligament. It 
is usually unilateral. Significant reduction in vibratory function of the mucosa is noted in 
stroboscopy. Vocal fold cysts do not resolve with voice therapy. Microlaryngoscopic surgery is 
needed and it is confirmed intra operatively by the presence of an encapsulated lesion. 
 
 
Fig.9 Vocal Fold Cyst 
Vocal fold fibrous mass: This lesion is typically amorphous and without encapsulation. It has a 
focal point within the vocal fold (seen stroboscopically) and can be palpated intra operatively. 
20 
 
Fibrous mass can be seen in the sub epithelium or in the ligament (FM-SE or FM-lig). Fibrous 
mass causes a significant diminution of vibratory function of mucosa. Histologically it contains 
fibrous material with prominent vascularity. They do not respond to voice therapy and micro 
laryngeal surgery is needed 
25 
 
 
Fig.10  Right vocal cord cyst and left vocal cord reactive lesion 
Reactive vocal fold lesions: Reactive vocal fold lesion has to be paired with a contra lateral 
vocal fold lesion. So it is unilateral. A reactive vocal fold lesion has a cup and saucer appearance, 
with the contra lateral lesion indenting the reactive vocal fold lesion at the point of maximum 
contact. The size of the reactive lesion is highly variable with respect to the contra lateral lesion. 
A reactive lesion will respond to voice therapy 
25
. 
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Non specific vocal fold lesions (NSVFL):  Vocal fold lesions in which the patient had 
symptomatic improvement with conservative therapy (non surgical), without resolution of the 
lesion size. Patients in this group had persistent lesions, but the lesions could not be defined 
further without a surgical exploration i.e. laryngoscopy and biopsy. The benign nature of these 
lesions as well as the reduction of the voice symptoms makes surgery avoidable. So a definitive 
diagnosis of the vocal fold lesion is not reached as the patient improved with non surgical 
therapy. These patients are described as having non specific vocal fold lesions NSVFL) 
25
.  
 The main symptoms on presentation of vocal fold lesions are hoarseness of voice, cough, 
foreign body sensation and throat pain
33
. The evaluation of the benign lesion is by indirect 
laryngoscopy (IDL) examination clinically and endoscopically using flexible laryngoscopes or 
with rigid endoscopes (70 degree or 90 degree). The most accurate investigation is stroboscopy 
which gives an idea on characteristics of the lesion and about the mucosal wave pattern. Recently 
for diagnostic purposes, the use of innovative technology such as ultra sonography and virtual 
laryngoscopy is being explored
34
. The benign vocal fold lesions can be managed with 
conservative therapy including voice therapy and anti reflux measures.  Micro laryngeal surgery 
and voice therapy is the mainstay of treatment for benign vocal fold lesions. With the 
introduction of lasers, lesions can be precisely excised.  The treatment for benign lesions of the 
vocal folds consists of a triad of microlaryngeal surgery, voice rest and vocal rehabilitation 
31
. 
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Fig.11 Microlaryngoscopy with chest suspension on the patient. 
 
Pre malignant lesions of the vocal cord 
 The most accepted definition of neoplasm is the one proposed by Rupert Willis in the 
1930s. He described neoplasm as “an abnormal mass of tissue, the growth of which is exceeds 
and is  un coordinated with that of normal tissues, and that persists in the same excessive manner 
after the cessation of the stimulus which evoked the change”35. Transition from normal laryngeal 
epithelium to squamous cell carcinoma (SCC) is related to progressive accumulation of genetic 
changes leading to a clonal population of transformed epithelial cells. The whole spectrum of 
histological changes ranges from squamous hyperplasia to carcinoma in situ (CIS).  Even after 
extensive research into the genetic changes in laryngeal carcinogens, reliable genetic markers 
23 
 
with diagnostic and prognostic value are still lacking. 90% of laryngeal carcinomas are 
developing from pre malignant lesion
36
. World Health Organisation (WHO) defined pre 
malignant lesions as “morphological alterations of the mucosa caused by chronic local irritative 
factors or referable to local expression of generalised illness, presenting a higher probability of 
degeneration into carcinoma with respect to surrounding mucosa”37. The diagnosis of a pre 
malignant lesion of the larynx must be based on the histological characteristics of the lesion 
34
. 
The various histological classifications are based on the presence of hyperplasia and/or 
dysplasia. Even though various authors proposed different grading systems, the commonly 
accepted are mainly three classifications, The WHO classification (2005), Squamous Intra 
epithelial Neoplasia (SIN) and Ljubljana classifications
38
.  Very early lesions show hyper 
keratosis or para keratosis without cellular atypia or dysplasia. Squamous cell dysplasia is 
characterised by cellular atypia, loss of normal maturation and stratification short of CIS. In mild 
dysplasia, the cellular abnormalities are minor and are limited to the basal one third of basal 
epithelium. Moderate dysplasia shows cellular abnormalities involving up to two third of the 
epithelial thickness. Severe dysplasia has cellular abnormalities involving more than two third of 
the epithelial thickness. Carcinoma in situ (CIS) is an intra epithelial neoplasm in which the full 
thickness of the squamous epithelium shows the cellular features of carcinoma without violation 
of the basement membrane and stromal invasion
39
. 
 
 The World Health Organization (WHO) classifies 
37 
pre malignant laryngeal lesions into 
six groups as 
1. Hyperplasia 
2. Keratosis 
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3. Mild dysplasia 
4. Moderate dysplasia 
5. Severe dysplasia 
6. Carcinoma in situ (CIS) 
 
 According to SIN (Squamous Intraepithelial Neoplasia) classification 
36
, there are only 
three groups are present 
1. SIN 1 
2. SIN 2 
3. SIN 3 
 
 According to Ljubljana Classification, the pre malignant lesions of larynx are divided 
into four groups 
5
, 
1. Simple Hyperplasia 
2. Abnormal Hyperplasia 
3. Atypical Hyperplasia 
4. Carcinoma in situ 
  
 In this classification, the Simple Hyperplasia (SH) is a benign group, Abnormal 
Hyperplasia (AbH) is a benign group, Atypical Hyperplasia (AtH) is a potentially malignant 
group and Carcinoma in situ (CIS) is malignant. 
 
The comparison of various grading is as follows: 
25 
 
 
 
Table.1  Comparison of various classifications of pre malignant lesions. 
 
 
2005 WHO Classification 
 
 
 
 
 
Squamous 
 
Intraepithelial 
 
Neoplasia (SIN) 
 
Ljubljana Classification 
 
Squamous  Intraepithelial 
 
Lesions (SIL) 
Squamous cell 
hyperplasia 
 Squamous cell (simple) 
hyperplasia 
Mild dysplasia 
 
SIN 1 
 
Basal/parabasal cell 
hyperplasia* 
Moderate dysplasia SIN 2 Atypical hyperplasia** 
Severe dysplasia SIN 3*** Atypical hyperplasia** 
 
Carcinoma in-situ 
 
SIN 3*** 
 
Carcinoma in situ 
*Basal/Parabasal cell hyperplasia may histologically resemble mild 
dysplasia, but the former is conceptually benign lesion and the 
latter the lower grade of precursor lesions 
** 'Risky epithelium'. The analogy to moderate and severe dysplasia is 
approximate 
*** The advocates of SIN combine severe dysplasia and carcinoma in-situ 
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 Further progression of premalignant lesions of the vocal cord lead to malignancy, mostly 
squamous cell carcinoma where the tumour is staged as follows according to the TNM 
classification. 
T1 - Tumour limited to vocal cord(s) (may involve anterior and posterior commissure) with   
       normal mobility.                                                                         
T1a – Tumour limited to one vocal cord. 
T1b – Tumour involves both vocal cords 
T2   – Tumour involves supra glottis and / or subglottis and /or with impaired vocal cord mobility 
T3   – Tumour limited to larynx with vocal cord fixation and/or invades paraglottic space and / or  
          minor thyroid cartilage erosion. 
T4a – Tumour invades through thyroid cartilage and / or invades tissue beyond the larynx (eg:      
           trachea, soft tissues of neck including deep extrinsic muscles of the tongue, strap    
            muscles, thyroid or oesophagus) 
T4b – Tumour invades pre vertebral space, encases carotid artery or invades mediastinal  
           structures.   
 
 Simple and abnormal hyperplasia is considered benign forms with 0.7% and 1% risk of 
malignant transformation respectively 
5
. Malignant transformation of mild dysplasia is reported 
27 
 
as 11%
40
. Atypical and severe dysplasia are associated with highest risk of cancer ranging from 
19% to 28%
41, 42
. 30% of patients with dysplastic lesions that progressed to invasive cancer 
eventually underwent total laryngectomy
38
. Almost all diffuse lesions showing CIS developed 
invasive cancer
43
.  
 Malignant transformation is a multi step process that takes many years. Blackwell and 
colleagues observed a 3.9year interval between initial biopsy to progression to invasive cancer 
40
. 
In a series of more than 1000 keratosis larynx, the mean time interval to malignant 
transformation was 3.1 years
44
. The latency was longer for earlier lesions, and 7% of lesions 
transformed into invasive carcinoma more than 10 years after the initial biopsy. Lesions showing 
mild dysplasia and even those without dysplasia may progress into invasive cancer.  A long term 
follow up of all pre malignant lesions is warranted as they may develop into carcinoma even 
after many years
45
. 
 
 
 
Fig.12 Bilateral vocal cord dysplasia 
28 
 
  
 The laryngeal pre malignant lesions have no specific macroscopic appearance. They are 
clinically referred as
40
 
1. Chronic laryngitis. 
2. Keratosis 
3. Leukoplakia 
4. Erythroplakia 
5. Hyperplastic-dysplastic lesions. 
 The surface morphology and keratin layer formation of these lesions has no specific 
meaning, nor any significant relationship with their malignant potential
46
. The histopathological 
diagnosis guides a clinician for the treatment of patients with benign, potentially malignant or 
actually malignant lesions. 
 
Fig.13 Left vocal cord keratosis 
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Management of pre malignant lesions:  Conservative measures can be tried for one month in 
the absence of a) worsening of vocal symptoms, b) an enlarging lesion c) clinical signs of 
invasive carcinoma. Conservative measures include proper hydration, elimination of vocal abuse; 
reduce the risk factors especially to stop smoking and alcohol intake. All patients with 
laryngopharyngeal reflux should be treated with proton pump inhibitors 
5
. 
 Chemoprevention with retinoid, selenium and other agents are still a matter of debate.  
However clinical response to retinol palmitate for laryngeal hyperplasia with an induction dose 
of 3,00,000 IU followed by a maintenance dose of 15,00,000 IU was assessed by Issing and 
colleagues
47
. There was a complete response in 75% of patients and a partial response in the 
remaining. None of these lesions progressed to cancer. One principal drawback to using retinoids 
is that the lesions tend to recur when the treatment is discontinued. 
 The management decision is mainly depending on whether there are single or multiple 
lesions or widespread disease 
5
. Single and multiple lesions should be completely excised to all 
visible margins, if possible. In case of wide spread disease, histopathological mapping of the 
lesion with multiple biopsies should be performed initially followed by a staged resection if 
feasible. Other factors which are important in deciding the management are patient’s general 
condition, fitness for surgery, age, co morbidity and presence of other risk factors 
5
.  The 
treatment of a premalignant lesion should aim to eradicate the lesion while preserving the voice 
quality and laryngeal function. Accurate histopathological diagnosis is critical for proper 
decision making. Hyperplastic and dysplastic lesions are excised with microlaryngoscopic 
techniques to remove the visible lesions. Close follow up is required due to risk of recurrence of 
the lesion and chance of malignant transformation. Carcinoma in situ may be treated with either 
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surgery or radiotherapy (RT). Surgical management is microlaryngoscopic excision. The carbon 
dioxide (CO2) laser is useful for precise excision, although thermal injury to underlying lamina 
propria may occur. Vocal cord stripping is the removal of the mucosa of the vocal fold including 
the lesion from the vocal process up to the anterior commissure. Surgical treatment is preferred 
for focal lesion in patients who are reliable and will attend routine follow up. Radiation therapy 
is also an effective treatment for Carcinoma in situ (CIS). A recent study of Carcinoma in Situ 
(CIS) treated with RT shows that the local control rate was 93.5%
38
. Radiation therapy is 
particularly useful for patients with multiple recurrences following surgical excision, for diffuse 
lesions, for patients who can’t attend regular follow up and for patients unfit for general 
anaesthesia. Voice quality is well preserved following radiation therapy
48, 49
. 
 In recent years, in office management of pre malignant lesions has become more 
common. This includes the treatment of pre malignant lesions with fibre based laser systems 
such as the Pulsed Dye Laser (PDL) and the pulsed KTP laser and by Photo Dynamic Therapy 
(PDT). 
 The 585nm PDL and 532nm pulsed KTP lasers are the two most widely used lasers for 
the in office treatment of laryngeal lesions including leukoplakia, keratosis and dysplasia. In a 
study by Franco and colleagues, PDL used for the treatment of dysplasia in the operating room 
under general anaesthesia. In most cases the treated lesions were then excised and sent for 
histopathological examination. The treatment was effective: 81% of patients had greater than 70 
% of regression of their lesion
50
. The same authors demonstrated the efficacy of PDL delivered 
via a flexible endoscope in the office for the treatment of dysplasia
51
. Zeitels et al have adopted 
the pulsed KTP laser for in office use, citing smaller fibre diameter, greater reliability, improved 
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intra lesional energy absorption, and improved haemostasis as advantages of the pulsed KTP 
system over PDL
52
.  The energy from these lasers is preferentially absorbed by oxyhaemoglobin, 
with the absorption of energy from the pulsed KTP being superior to that of PDL, causing photo 
angiolysis of the sublesional blood vessels
50
.  Preferential destruction of intraepithelial 
desmosome junctions and separation of the treated epithelial cells from the basement membrane 
have also been observed microscopically
53
. Apart from the obvious advantages of in-office 
procedures (avoidance of general anaesthesia, lower cost, improved efficiency, and patient 
preference), these lasers have minimal effect on the surrounding tissue and the scarring is 
uncommon. The bilateral simultaneous treatment of lesions in and around the anterior 
commissure is possible, with minimal risk of web formation
54
. One of the major criticisms of in-
office procedures for the treatment of laryngeal lesions, especially dysplasia, is that there is no 
specimen obtained for pathologic examination, and therefore a definitive assessment of the 
tumour extent and margin status is not possible. In the reports published to date, all patients have 
been biopsied before the commencement of treatment 
50, 52. 
 A biopsy may be obtained in the 
operating room and initial treatment with the laser given at this time, or it may be taken in the 
office via the endoscope. Potential complications of in-office treatment include poor exposure of 
the lesion or poor patient tolerance of the procedure; however, these issues only arise in a small 
minority of cases 
52
.  Further studies with long-term follow-up are awaited to ensure that this 
novel technology has similar outcomes for patients with dysplastic laryngeal lesions. 
 Photodynamic therapy uses nontoxic chemicals that are taken up preferentially by 
dysplastic or malignant cells. These photo reactive chemicals are activated by light of a specific 
frequency range unique to the compound used. The light activation of tissues at the target site in 
the presence of oxygen results in cell death that is confined to the cells that have selectively 
32 
 
accumulated the chemical
55
. Several agents have been used in the head and neck cancers 
including 5-ALA, Photofrin, haematoporphyrin derivative, and Foscan. In the United States 
several photosenstitisers have been approved for use by the Food and Drug Administration, but 
treatment of head and neck malignancies is an off-label use at the present time. In the European 
Union, Foscan has been approved for treatment of early head and neck cancer. At present, data 
are available for approximately 1500 subjects treated with PDT for head and neck SCC 
53
. Biel 
reported on 115 patients with Tis to T2 larynx SCC treated with Photofrin PDT. With a mean 
follow-up of 91 months, the 5-year cure was 91%. All recurrences were salvaged successfully 
53
. 
Photodynamic therapy has several advantages: it is performed in an outpatient setting and is 
repeatable. The effects on voice quality are minimal, and scarring of the vocal folds has not been 
observed 
53
. Careful light-avoiding precautions are required because light sensitivity lasts up to 4 
weeks. There is no pathologic specimen, and care must be taken to accurately assess tumour 
depth. PDT may have a particularly useful role for diffuse dysplasia or CIS.  Schweitzer reported 
80% local control with PDT in 10 cases of diffuse laryngeal CIS previously treated with RT
56
.  
Published reports show promise for the use of Photo Dynamic Therapy (PDT), but currently it is 
used only in selected centres and is not widely available. 
Screening for Laryngeal carcinoma 
 Attempts to screen the laryngeal cancer have met with little success as the populations 
who would benefit most from screening are those least likely to seek it, especially the elderly 
male population with low socio economic status.  The standard of screening for laryngeal 
carcinoma is by flexible laryngoscopy by an experienced surgeon or the review of the images or 
videos of the laryngoscopy by an expert. This makes the screening not cost effective and time 
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consuming. An acoustic screening method to find out the possibility of laryngeal cancer has been 
investigated
57
. Three acoustic parameters named pertuberations in pitch period, peak amplitude 
sequences and vocal noise of a sustained vowel, “e” were measured. The combined use of these 
parameters enabled to build an acoustic screening system for laryngeal cancer 
55
. But the routine 
use of this system is not known.  In a study by Fischinger J, and Mlacak B
58
 in Slovania, the 
authors concluded that screening does not always result in the hoped for outcome. It also requires 
much time and effort.  They even question the justification of yearly examinations of the 
populations at risk, even though some authors consider this to be feasible. More important than 
screening is public health education which is primarily the responsibility of general practitioners 
as well as the laryngologists 
56
. 
Studies on techniques to diagnose premalignant and malignant lesions of vocal cords 
 The visual appearance of a premalignant laryngeal lesion does not predict its histologic 
nature.  Pre operative investigations like videostroboscopy also do not reliably differentiate 
premalignant from malignant lesions
59
. Biopsy is the gold standard for diagnosis and adequate 
sampling of the suspected area is important for the management. Various adjunctive techniques 
have been developed to improve the clinician’s ability to characterise these lesions, to guide 
biopsies and to aid in resection of the vocal cord lesions intra operatively using 
microlaryngoscopic techniques or by laser resection. 
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Fig.14 Malignant lesion left vocal cord. 
 
The various methods which are used for detection of pre malignant and malignant lesions are 
1. Vital dyes like toluidine blue and methylene blue. 
2. Contact endoscopy 
3. Autofluorescence endoscopy 
4. Induced autofluorescence using 5-aminolevulinic acid (5-ALA) 
5. Compact endoscopy 
6. Optical coherence tomography (OCT) 
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 Vital dyes are chemicals which can be used safely in live tissues. The use of vital dyes 
like toluidine blue and methylene blue as an adjunctive tool for the evaluation of pre malignant 
lesions have been investigated
60, 61
. Lundgren and colleagues used toluidine blue to detect 
dysplasia or malignant changes and noted 91% sensitivity, but only 52% specificity 
59
. Even 
though Lugol’s iodine is a vital dye and it has been using in the lesions of the oral cavity, 
oropharynx and oesophagus, no studies have investigated its use in vocal cord lesions. 
 Contact endoscopy provides magnification of 50 to 60 times and, with methylene blue 
staining, provides histologic information and assessment of vascular patterns
62
. However, the 
subsurface visualisation is limited only to 150 to 200 microns and is inadequate for 
characterizing thicker lesions. Widespread use of this technique has been limited by the need for 
extensive experience to interpret the findings and for the special equipment. 
 Human tissue has many compounds that fluoresce when exposed to blue light. The 
difference in fluorescence of abnormal tissues has been exploited as a diagnostic tool for 
laryngeal malignancy. Limitations include the need for adequate experience in the technique, 
false-positive and false-negative examinations in scarring, hyperkeratotic lesions, and 
inflammation
63
. 
 Induced autofluorescence using 5-aminolevulinic acid (5-ALA) also shows potential 
diagnostic utility. 5-ALA selectively induces accumulation of protoporphyrin IX fluorescence in 
tumours. Using a nebulizer, it is topically applied 1 to 2 hours before the examination and a light 
source emitting short wavelength visible light (375 to 440 nm) is used to induce fluorescence. 
Protoporphyrin IX fluorescence appears red during imaging. In a study by Mehlmann et al, a 
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series of 16 patients with suspected or proven laryngeal malignancy subjected to 5-ALA–induced 
fluorescence endoscopy demonstrated a sensitivity of 95% and a specificity of 80%
64
. 
    A prospective evaluation of autofluorescence and 5-ALA–induced fluorescence in 56 
patients demonstrated that the two techniques have similar sensitivities (94% and 97%) and 
specificities (82% and 64%) to distinguish hyperplasia or mild dysplasia from moderate 
dysplasia, severe dysplasia, CIS, and invasive SCC
65
.  Autofluorescence was unreliable when 
scarring was present, whereas 5-ALA–induced fluorescence resulted in false-positive findings in 
inflamed lesions. 
 The combined use of autofluorescence and contact endoscopy (“compact endoscopy”) 
has also been investigated. A study by Arens and colleagues of 83 patients with hyperkeratotic, 
dysplastic, and invasive laryngeal lesions found correlation with histology in 88% of cases 
63
. 
Inflammation and scarring resulted in overestimation of disease, whereas underestimation of 
disease was seen in hyperkeratotic lesions. 
 Current non-invasive diagnostic modalities do not reliably distinguish premalignant 
lesions from invasive SCC. Optical and microscopic imaging is limited by the inability to see 
below the first few layers of epithelial cells to evaluate the submucosal architecture. Infrared 
light has increased tissue penetrance and can provide diagnostic information about subsurface 
tissues. Optical coherence tomography (OCT) is a new diagnostic modality under investigation 
to examine the epithelial and subepithelial architecture that uses near-infrared light waves to 
produce cross-sectional images of tissue in vivo, with a resolution nearing that of histology
66, 67
. 
In the larynx, OCT clearly identifies basement membrane violation from laryngeal cancer and is 
able to identify transition zones at the margins of the cancer
68
. OCT has been used to assess the 
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larynx intraoperatively to guide the extent of transoral laser resections for laryngeal cancer to 
ensure that excision is complete
69
. The primary disadvantage of OCT is the limited depth of 
penetration (<2 mm), which limits its utility in bulky lesions. However, OCT has potential as a 
useful tool in the management of laryngeal cancer: for the diagnosis of smaller epithelial lesions, 
for guiding surgical biopsies and resections, and for monitoring larynges post treatment. 
 
Lugol’s iodine:  Basic facts and studies on effects of Lugol’s iodine in oral 
cavity, oropharynx and oesophagus. 
 The vital dyes are an auxiliary technique used in vivo to evidence suspicious lesions and 
to better define the existing lesion’s margin and extension 6. These vital dyes are capable of 
penetrating living cells and binding to specific biological structures. 
  Lugol’s iodine, also known as Lugol’s solution first made in 1829, named after the 
French physician JGA Lugol (1786-1851), has a high affinity for glycogen in non keratinized 
squamous epithelium
70
. 
 Lugol’s iodine is a solution of elemental iodine and potassium iodide in water. Original 
Lugol’s solution contain 5gms of iodine and 10gms of potassium iodide mixed with 85ml of 
distilled water, with a total iodine content of 150mg/ml 
6
. The first use of iodine staining to 
detect mucosal abnormalities was described by Schiller, the Austrian – American gynaecologist 
and pathologist in 1933. He used this technique to highlight squamous lesions in the cervix
71
, 
hence the name Schiller’s test, came for vital dye with Lugol’s iodine. 
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Fig.15  Lugol’s iodine 
  
 The principle of iodine staining is that iodine reacts with glycogen in the cytoplasm, and 
this reaction is known as Iodine - starch reaction, is visualized by a colour change. Tissue 
glycogen content is always related to the degree of keratinisation. Glycogen content is inversely 
proportional to the degree of keratinisation 
6. Iodine is glycophilic and the application of Lugol’s 
iodine solution results in uptake of iodine in normal glycogen containing epithelium and stains 
the mucosal surface to Mahogany brown or black
72
. In para keratinised stratified squamous 
epithelium, the cells in the intermediate and superficial layer contains glycogen in their 
cytoplasm. In contrast dysplastic or invasive cancer cells contain little glycogen and these areas 
do not take up iodine and remained as unstained lesions 
70. Various concentrations of Lugol’s 
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iodine solution were used in different studies: 1.25%, 1.5%, 2%, 3%, 5% and 10% (65=6).  In a 
study by Sreedharan et al 
73
, the authors recommend the use of 1.5% of Lugol’s iodine in the 
chromoendoscopic studies in oesophagus. 
 
 
Fig.16  Application of Lugol’s iodine in the evaluation of tongue lesions. The lesion shows 
unstained pattern  
  
 In a study by McMahon J et al 
70, they used Lugol’s iodine in the resection of oral and 
oropharyngeal squamous cell carcinoma. Visualisation of intra epithelial neoplasia with Lugol’s 
iodine is the method chosen for the margin of resection.  They suggest that Lugol’s iodine is a 
simple, inexpensive, and apparently effective means of reducing the likelihood of unsatisfactory 
surgical margins in the resection of oral and oropharyngeal squamous cell carcinoma. 
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 In a study by Maeda K et al
74
, colorimetric analysis of unstained lesions surrounding oral 
squamous cell carcinomas and oral potentially malignant disorders using iodine were studied. 
They noted that after using 3% Lugol’s iodine, the colour difference allow easier detection of 
unstained lesions with a clear border, which helps in resection of the lesion in oral cavity. They 
conclude that the colour charts prepared on the basis of measures of lightness and hue 
reproduced the macroscopic colour differences in unstained lesions(USL), suggesting that it may 
become possible to diagnose unstained lesions (USL) histologically on the basis of the measured 
colour values and use of colour charts to help determine the resection area in surgery. 
 Massimo and colleagues 
6, reviewed studies on the use of Lugol’s iodine in oral cancer 
diagnosis. They found out that Lugol’s iodine has a sensitivity of 0.875 and specificity of 0.842 
in detecting oral squamous cell carcinoma. It has less sensitivity in identifying oral malignant 
and dysplastic disease but it was of greater specificity. The authors conclude that, all the studies 
analysed found the Lugol’s solution to be effective, cheap and easy to use and they emphasized 
its importance in clinical practice.  
 Yajima et al 
75
, quantified the telomerase activity of unstained areas (after application of 
Lugol’s iodine) surrounding oral squamous cell carcinoma. In all cases the unstained areas 
showed a statistically significant increase in telomerase activity, thus confirming the role of 
Lugol’s solution in detecting the margin of oral squamous cell carcinoma. 
 In a study by Stanford and colleagues
76, describes the use of Lugol’s iodine in detecting 
high grade squamous dysplasia and invasive carcinoma, in oesophagus during oesophagoscopy. 
They found out mucosal iodine staining is a very sensitive technique for detecting the precursor 
and early invasive lesions of squamous oesophageal carcinoma.  
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Fig.17. Application of Lugol’s iodine in oesophagoscopy to detect pre malignant and 
malignant lesions (as evidenced by unstained areas) 
 
 They recommend the use of Lugol’s iodine for optimal visualisation of oesophageal 
squamous mucosal abnormalities during endoscopy (oesophagoscopy). In that study after 
staining with Lugol’s iodine, the sensitivity of USL (Un Stained Lesions) for identifying high 
grade dysplasia or carcinoma was 96% and the specificity was 63%. They also noted that after 
staining with Lugol’s iodine the lesions were larger or more clearly defined. They concluded that 
the use of Lugol’s iodine during oesophagoscopy is safe, inexpensive, simple and rapid to 
perform, easy to interpret and highly sensitive for all clinically important squamous neoplasia. It 
is essential for detecting many squamous dysplasias and for detecting the full extent of the 
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lesion. It should be used as a routine procedure in high risk populations and whenever an 
unexplained squamous mucosal abnormality is observed in low risk individuals 
74. 
 In effect Lugol’s Iodine is a routinely used vital stain in UADT malignancies screenings, 
it is safe, inexpensive, simple and rapid to perform, easy to interpret and highly sensitive for all 
clinically important squamous neoplasia. According to our search and understanding, the use of 
this method is not studied in glottic malignancies, hence this study. 
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MATERIALS AND METHODS 
 The purpose of the study is to identify the staining properties of the Lugol’s iodine in 
various vocal cord lesions and investigate the effectiveness of Lugol’s iodine in detecting various 
pre malignant and malignant vocal cord lesions. 
Type of study: Observational study 
Period of study: 1 year 
Settings: This study was performed in the ENT outpatient department and Operating room  at 
Christian Medical College, Vellore, between December, 2011 and November, 2012. All patients 
aged 18 years and above with hoarseness of voice for more than 4 weeks, and were scheduled to 
undergo microlaryngoscopic evaluation / surgery, were included in the study. 
Inclusion criteria: 
1. Patients with hoarseness of voice for more than 4 weeks. 
2. Age above 18 years. 
3. A written informed consent 
4. No history of allergy to iodine. 
Exclusion criteria: 
1. Patients who had undergone any surgery of the larynx or received any chemotherapy or 
radiotherapy for head and neck cancer. 
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2. Distant metastasis. 
3. Any history of allergy to iodine or any contrast material. 
Sample size calculation: 
 Taking into consideration that Lugol’s iodine has been used in the detection of oral 
squamous cell carcinoma, where it has been shown to have 85% sensitivity 
6
 and applying a 
precision of 10% and a confidence interval of 80%, a sample size of 88 was calculated. 
The sample size was calculated using the formula, 
n = 4PQ/d2, 
where, 
n = sample size 
P = sensitivity 
Q = 100 – P 
d = precision. 
Material: Lugol’s Iodine solution, 1.5% of concentration is used in the study.  It is prepared by 
mixing 1.5gm of Iodine and 3gm of Potassium Iodide in 100ml water. The cost of Lugol’s iodine 
is Rs. 1.10 per ml, which is cheaper than any dye used in the various studies including Toluidine 
blue. 1 ml of the dye is sufficient for use in single patient. 
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Methods: 
Study population recruitment:  Consecutive patients presenting in the ENT outpatient 
department with hoarseness of voice for more than 4 weeks and fulfilling inclusion and exclusion 
criteria, and were planned for microlaryngoscopic examination / surgery under general 
anaesthesia, were recruited after obtaining a valid informed consent.  Pre-operative evaluation 
included clinical examination and Nasopharyngolaryngoscopy (NPL scopy) using flexible 
laryngoscope (Karl Storz, Germany). The findings were noted and video recording of the lesion 
done using ‘IMIMO’ recording software (Avanttec Medical Systems Pvt Ltd). The findings were 
noted in the proforma (Appendix). 
Procedure: Under general anesthesia patients were examined by direct laryngoscopy and the 
suspected vocal cord lesion was visualised under microscope (Karl Zeiss) with a 400mm 
objective lens and 6X magnification.  Findings noted were recorded.  Features of suspected 
lesion were observed and their characteristic features like polyp / nodule / cyst / keratosis/   
growth were recorded.  Also the presence of the lesion on unilateral or bilateral cords, colour of 
the lesion, extent of the lesion, number of lesions (single or multiple etc) was noted. 
Applying the dye on the vocal cords: The saliva and mucous over the vocal cords are suctioned 
out and the remaining film of mucus is removed by wiping the surface of the entire vocal cord 
including the suspected area with dry cotton ball 3 times.  After confirming the entire surface is 
free of saliva or mucous, a cotton ball dipped in 1.5% Lugol’s iodine is applied over bilateral 
vocal cords in sweeping motion. Care is taken to avoid spillage in to the tracheo-bronchial tree. 
The dye is allowed to be absorbed for up to 1 minute, after which the staining pattern is observed 
for upto 3 minutes.  Based on staining patterns the lesions are noted as “stained” or “unstained”. 
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Stained - means Brown or Mahogany brown. 
Unstained – means remains white/pink/ takes the stain initially and turns to previous colour. 
The whole procedure is video recorded using the software Pinnacle Studio. (Pinnacle studio is a 
non linear video editing software application manufactured by Pinnacle System, a division of 
Avid Technology). The lesion on the vocal cord is excised using microlaryngoscopic techniques 
and specimen sent for histopathological examination.  The description of the lesion and the 
staining property are noted in the proforma. 
 Considering histopathological (HPE) report as gold standard, the study also compares the 
HPE report with the staining property. Also the study reports the staining property of Lugol’s 
iodine in various vocal cord lesions.  
Statistical analysis: 
 The data of all the patients collected systematically with the software EPIDATA version 
3.1.All statistical analysis were performed using statistical software STATA (version 10.0), 
STATA corporation, Texas, USA. The sensitivity, specificity, positive and negative predictive 
value calculated using this software.  
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RESULTS 
 A total of 89 patients participated in the study, of which 14 patients were having bilateral 
vocal cord disease. Hence a total of 103 samples were sent for histopathological examination 
(HPE), and correlated with the staining pattern.  The comparison was intended to correlate the 
unstained pattern of the suspected lesion indicating the presence of a pre malignant or a 
malignant lesion. 
Following are the various parameters that were observed: 
1. Sex ratio of the study population. 
 
 
Fig.18 Sex ratio of the patients. 
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 Of the total 89 patients, 92% (82 patients) are males and 8% (7 patients) are females. 
There is an evident male preponderance for vocal cord disorders. 
2. Age distribution pattern 
 
 
Fig.19 Age distribution of the patients. 
 The age range was 22 years to 82 years with a mean age of 52 years. Of the total 89 
patients, 8% (7 patients) are less than 30 years of age, 84% (75 patients) of patients are between 
30 to 60 years, and 8% (7 patients) are more than 60 years of age. This shows that the vocal cord 
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lesions are present more in the middle aged population than in the younger and elderly 
population. 
3. Duration of hoarseness of voice in study population 
 
Fig.20  Duration of the hoarseness of voice 
 
 In the present study, 56% (50 patients) of patients presented with hoarseness of voice less 
than 6 months of duration, 19% (17 patients) of patients presented with hoarseness of voice more 
than 6 months but less than 1 year, and 25% (22 patients) presented with hoarseness more than 1 
year duration. 
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4. Distribution of vocal cord lesions. 
 
9 
 
 
Fig.21 Distribution of the vocal cord lesions. 
 
 A total of 89 patients participated in the study. Of all the patients who presented with 
hoarseness of voice, 57% of patients (51 patients) were diagnosed to have benign lesions, 23% of 
patients (20 patients) had pre malignant lesions and 20% of patients (18 patients) had carcinoma. 
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This study shows that more than half of the patients who presented with hoarseness were having 
benign lesions. 
 
5. Sex distribution of various vocal cord lesions. 
 
 
 
Fig.22 Sex distribution of various vocal cord lesions 
 
 
 Of the total 89 patients 51 patients were diagnosed to have benign vocal cord lesions, of 
which 46 were male and 5 were females. In the pre malignant group, of the total 20 individuals, 
19 were male and only 1 was female. Of the patients who were diagnosed to have malignant 
lesion, of the total 18 patients, 17 were males and only 1 individual was female.  This indicates 
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an overall male preponderance in vocal cord lesions and particularly in pre malignant and 
malignant lesions. 
 
6. Distribution of various pre malignant lesions. 
 
 
 
Fig.23 Percentage of various pre malignant lesions. 
 
 Of the total 30 pre malignant lesions, 30% is hyperplasia (n=9), 13% is keratosis (n=4), 
13% mild dysplasia (n=4), 17% moderate dysplasia (n=5), 7% severe dysplasia (n=2), and 20% 
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carcinoma in situ (n=6).  This shows that hyperplasia is the most reported pre malignant lesion in 
vocal cords, followed by carcinoma in situ. 
 
7. Laterality of the lesion 
 
 
 
Fig.24 Laterality of the lesion. 
 
  
 Of the total 89 patients, 75 have unilateral lesions and 14 have bilateral lesions. Almost 1 
in every 5 cases had a bilateral lesion. 
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8. Presenting complaints of vocal cord lesions 
 
 
 
 
 
 
 
. 
 
  
 
 
 
 
Table.2 Presenting complaints of vocal cord lesions 
 
 
Each of the 89 patients in the study presented with hoarseness of voice of more than 4 weeks of 
duration (n=89). Other associated complaints were Globus pharyngeus (n=9), noisy breathing 
(n=4), dysphagia (n=0), odynophagia (n=0), neck swelling (n=0), bilateral ear pain (n=1), 
haemoptysis (n=1). Globus pharyngeus is the second commonest symptom. 
 
Presenting complaints Number of patients 
Hoarseness of voice 89 
Globus pharyngeus 9 
Dysphagia 0 
Noise breathing 4 
Neck swelling 0 
Bilateral ear pain 1 
Haemoptysis 1 
Odynophagia 0 
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9. Risk factors of various vocal cord lesions 
 
 
 
.                                    Fig.25  Risk factors for various vocal cord lesions 
 
 
 The various risk factors which are analysed in our study are smoking, pan chewing, 
alcohol intake, gastro esophageal reflux disease (GERD), and voice abuse.  Smoking was 
reported in 46.59% of patients (41 patients) and it is the most common risk factor in vocal cord 
lesions. Pan chewing was reported in 13.6% (12 patients), alcohol in 12.5% of patients (11 
patients), gastro esophageal reflux disease in 14.6% of patients (13 patients) and voice abuse in 
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39.7% of patients (35 patients). The most common risk factor in vocal cord neoplasm is 
smoking, followed by voice abuse. 
 
10. Prevalence of smoking in vocal cord lesions 
 
 
 
Fig.26 Prevalence of smoking in vocal cord lesions 
 
 
 History of smoking in present in 72% of patients with malignancy, 45% of patients with 
pre malignant lesions and only in 38% of patients with benign lesion. This shows a clear 
association of smoking in malignant lesions. 
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11. Prevalence of pan chewing in vocal cord lesions 
 
 
 
 
Fig.27 Prevalence of pan chewing in vocal cord lesions. 
 
 
 Pan chewing was reported in 16.6% of malignant lesions, 20% of pre malignant lesions 
and in 10% of benign lesions. 
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12. Prevalence of alcohol use in vocal cord lesions 
 
 
 
 
Fig.28  Prevalence of alcohol use in various vocal cord lesions. 
 
 
 History of alcohol use was present in 11.1% of malignant lesions, 20% of pre malignant 
lesions and in 10% of benign lesions. 
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13. Prevalence of Gastro oesophageal reflux disease in vocal cord lesions 
 
 
 
 
 
 
 
 
 
 
 
Fig.29 Prevalence of Gastro oesophageal reflux disease. 
 
 Gastro esophageal reflux disease is prevalent in 9% of benign lesions (5 patients), 10% of 
pre malignant lesions (3 patients), and in 27.7% of malignant lesions (5 patients). This indicates 
that there is a definite association between gastro oesophageal reflux disease and vocal cord 
pathology. 
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14. Prevalence of voice abuse in vocal cord lesions. 
 
 
 
Fig. 30 Prevalence of voice abuse. 
 
 Voice abuse is reported in 52% of benign lesions (26 patients), 30% of pre malignant 
lesion (6 patients) and in 16.6% of malignant lesions (3 patients). This indicates that benign 
lesions have a definite association with voice abuse. Of the total 18 malignant cases, 2 patients 
(11% of patients) have only voice abuse as risk factor, In the case of pre malignant lesions of the 
total 30 patients 5 presented with voice abuse as the only risk factor. 
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15. Staining pattern of Lugol’s iodine in various lesions. 
 
A. Benign lesions 
 
 
 
Fig.31 Staining pattern of Lugol’s iodine in benign lesions. 
 
 Of the total 55 benign lesions 78% showed staining with Lugol’s iodine.  This matches 
with the hypothesis that benign lesions should stain with Lugol’s iodine. 
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B. Malignant lesions 
 
 
 
Fig.32 Staining pattern of Lugol’s iodine in malignant lesions. 
  
 Of the total 18 malignant lesions (squamous cell carcinoma) 88.88% (16 patients)   
remained unstained. This matches with the hypothesis that malignant lesions remain unstained 
after application of Lugol’s iodine. 
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C. Pre malignant lesions 
 
 
 
Fig.33 Staining pattern of Lugol’s iodine in various pre malignant lesions. 
 
 As per the WHO classification of pre malignant lesions of vocal cords, the six groups of 
pre-malignant lesions were evaluated in our study (i.e. hyperplasia, keratosis, mild dysplasia, 
moderate dysplasia, severe dysplasia, and carcinoma insitu.). As we move high in the spectrum 
i.e. from hyperplasia to carcinoma in situ, the staining pattern changes from “stains” to 
“unstained”. Of the 9 cases of hyperplasia, 7 cases stained and 2 cases remained unstained 
0
20
40
60
80
100
120
STAINING PATTERN IN PRE MALIGNANT 
LESIONS 
%STAINED
% UNSTAINED
64 
 
(22.2% cases were unstained). In keratosis, of the total 4 cases, 1 case stained and 3 cases 
remained unstained (75% of cases were unstained). In mild dysplasia, of the 4 cases, all the 4 
cases were stained brown during the application of Lugol’s iodine (0% of cases were unstained). 
In moderate dysplasia, of the total 5 cases, 3 cases stained and 2 remained unstained (40% of 
cases were unstained). In severe dysplasia (2 cases) and carcinoma in situ (6 cases), all remained 
unstained after Lugol’s iodine application. i.e. 100% lesions showed “unstained” pattern.  This 
shows that in high risk cases i.e. severe dysplasia and carcinoma in situ, Lugol’s iodine is an 
effective tool in identifying the lesion intra operatively. 
 
16. Sensitivity and specificity of Lugol’s iodine in detecting squamous cell carcinoma. 
 
 MALIGNANT PRE 
MALIGNANT 
BENIGN TOTAL 
UNSTAINED 16 14 12 42 
STAINED 2 16 43 61 
TOTAL 18 30 55 103 
 
Table.3  Staining pattern of Lugol’s iodine in various  vocal cord lesions. 
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1. Sensitivity of Lugol’s iodine in detecting malignant lesions are calculated as 
 
  
  
    = 88.88% 
 
(95% confidence interval 65.29% - 98.62%) 
 
2. Sensitivity of Lugol’s iodine in detecting pre malignant lesions are calculated as 
  
  
            
(95% confidence interval 28.34% - 65.67%) 
 
 
3. Specificity of Lugol’s iodine in detecting pre malignant or malignant lesions are 
  
   
            
 
(95% confidence interval 64.99% -   88.19%) 
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17. Positive predictive and negative predictive value of Lugol’s iodine in detecting malignant 
lesions: 
 
 MALIGNANT BENIGN TOTAL 
UNSTAINED 16 12 28 
STAINED 2 43 45 
TOTAL 18 55 73 
 
 
Table.4  Staining pattern of Lugol’s iodine benign and malignant vocal cord lesions 
 
     Positive predictive value for malignant lesions, 
PPV   
    
  
          % 
(95% confidence interval 37.18%-   75.54%) 
 
Negative predictive value for malignant lesions, 
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NPV   
    
  
            
(95% confidence interval  84.85%-   99.46%) 
 
 
18. Positive predictive and negative predictive value of Lugol’s iodine in detecting pre 
malignant lesions: 
 
 PRE 
MALIGNANT 
BENIGN TOTAL 
UNSTAINED 14 12 26 
STAINED 16 43 59 
TOTAL 30 55 85 
 
 
Table.5  Staining pattern of Lugol’s iodine in premalignant and benign vocal cord lesions 
 
Positive predictive value for pre malignant lesions, 
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PPV   
    
  
          % 
(95% confidence interval  33.37%-   73.41%) 
 
Negative predictive value for pre malignant lesions, 
NPV   43/59             
(95% confidence interval  59.73% -  83.64% ) 
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DISCUSSION 
 Cancer of the larynx is the second most common malignancy of the upper aerodigestive 
tract (UADT) 
1
.  This accounts for approximately 1.7% of all new cancer diagnosis, 25% of all 
head and neck malignancies and in 90% of cases is squamous cell carcinoma
2.
 In India, laryngeal 
carcinoma constitutes 2.63% of all body cancers. It is ten times more common in males than 
females (4.79% vs 0.47%)
 9.  
Smoking, alcohol, chemical exposure, laryngopharyngeal reflux, 
viral etiology and diet are considered as the risk factors associated with laryngeal cancer.  
Squamous cell carcinoma of the larynx is strongly associated with the use of tobacco and 
alcohol. They are the two strongest aetiological factors for the development of Head and Neck 
Squamous Cell Carcinoma (HNSCC), both independently and synergistically 
12,13.
  This has been 
the same in our study too.  The most common site for laryngeal squamous cell carcinoma is the 
glottic larynx 
3
. 
   90% of laryngeal carcinomas are developing from pre malignant lesions 
33
. The diagnosis 
of a pre malignant lesion of the larynx must be based on the histological characteristics of the 
lesion
34
. The World Health Organization (WHO) classifies 
29
 pre malignant laryngeal lesions 
into six groups as Hyperplasia, Keratosis, Mild dysplasia, Moderate dysplasia, Severe dysplasia, 
and Carcinoma in situ (CIS). All premalignant lesions have the potential to transform to 
carcinoma. Lesions showing mild dysplasia and even those without dysplasia may progress into 
invasive cancer 
5, 38, 39,40,41,42.
  So it is essential to identify all premalignant lesions early. A long 
term follow up of all pre malignant lesions is warranted as they may develop into carcinoma 
even after many years 
43.
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 The visual appearance of a premalignant laryngeal lesion does not predict its histologic 
nature.  Pre operative investigations like videostroboscopy also do not reliably differentiate 
premalignant from malignant lesions 
57.
 Biopsy is the gold standard for diagnosis and adequate 
sampling of the suspected area is important for the management. Various adjunctive techniques 
have been developed to improve the clinician’s ability to characterise these lesions, to guide 
biopsies and to aid in resection of the vocal cord lesions intra operatively using 
microlaryngoscopic techniques or by laser resection. 
 The various techniques used for detection of pre malignant and malignant lesions are the 
use of  vital dyes like toluidine blue and methylene  blue, contact endoscopy,  autofluorescence 
endoscopy, induced autofluorescence using 5-aminolevulinic acid (5-ALA), compact endoscopy, 
optical coherence tomography (OCT). 
 Lugol’s iodine in the chromoendoscopic studies in oesophagus 71 is now being accepted 
as a reliable screening tool in peripheral and less equipped settings. In our study of the total 89 
patients, 92% (82 patients) are males and 8% (7 patients) are females. There is an evident male 
preponderance for vocal cord disorders in all the three category i.e. benign, pre malignant and 
malignant lesions. In case of  malignant lesions, our study shows a male to female ratio 17:1, 
which shows a higher population of male patients affected with laryngeal carcinoma comparing 
the study by  Babak Saedi et al 
7
, which shows the male to female ratio is 9.5:1.  In worldwide 
also the overall male-to-female ratio is about 4:1 to 10:1 as evidenced by various studies 
8
,
77
. 
 In a study by Muhammad Rashid Zia et al
78
  the mean age for presentation of laryngeal 
malignancy is 54, which is comparable with our study which reported the mean age as 52 years 
and 84% patients are in the middle aged populations (30-60years). 56% patients presented with 
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hoarseness of voice of less than 6 months duration, this matches with the classical teaching that 
vocal cord lesions present early. 
 In our study, in those patients who presented with hoarseness of voice, the distribution of 
vocal cord lesions are as follows: 57% of patients presented with benign lesions, 23% presented 
with premalignant lesions and 20% presented with carcinoma. This finding contradicts the study 
by Iseh KR et al, which showed that 66.7% of the vocal cord lesions are malignant and 33.3% 
are benign lesions
79
. No studies clearly mention the distribution of pre malignant lesions. 
 Regarding distribution of pre malignant lesions in the glottis, our study shows the 
following results in decreasing order: Hyperplasia 30%, Carcinoma in situ 20%, Moderate 
dysplasia 17%, Keratosis 13%, Mild dysplasia 13%, and Severe dysplasia 7%, which shows 
hyperplasia is the most common premalignant condition in vocal cords followed by carcinoma in 
situ. No studies have clearly reported the distribution of pre malignant lesions before. 
 Our study shows that 84% of patients who presented with hoarseness of voice have single 
cord lesions and 16% have bilateral lesions, i.e. 1 in every 5 patient had bilateral vocal cord 
lesions. This is in contrast to the results obtained by Swapan K Ghosh et al
80
 who reported the 
ratio of unilateral and bilateral affection was near about 5: 4. 
 In our study other than hoarseness of voice which is present in all the patients, the other 
symptoms at presentation in the decreasing order are globus pharyngeus, noisy breathing, 
dysphagia, odynophagia, neck swelling, bilateral ear pain and haemoptysis. Next to hoarseness 
of voice, globus pharyngeus is the most common symptom. On comparing the study by 
Muhammad Rashid Zia et al 
76
 our study agree in the symptomatology of laryngeal malignancy. 
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 The various risk factors which are analysed in our study are smoking, pan chewing, 
alcohol intake, gastro esophageal reflux disease, and voice abuse.  Smoking was reported in 
46.59% of patients and it is the most common risk factor in vocal cord lesions. Others in the 
decreasing order are voice abuse in 39.7% of patients, gastro esophageal reflux disease in 14.6% 
of patients, pan chewing in 13.6% and alcohol in 12.5% of patients. While analysing smoking 
alone in the study, history of smoking was present in 72% of patients with malignancy and 45% 
of patients with pre malignant lesions and only in 38% of patients with benign lesion. This shows 
a clear association of smoking with malignant lesions. History of alcohol use was present in 
11.1% of patients with malignant lesions, 20% of pre malignant lesions and in 10% of benign 
lesions. In previous studies 
12, 13, 14 
it is reported that alcohol act synergistically with smoking and 
has a definite role in carcinogenesis, our study shows only 11.1% of patients with malignant 
lesions have alcohol use. 
 Pan chewing was reported in 16.6% of malignant lesions, 20% of pre malignant lesions 
and in 10% of benign lesions. We strongly suspect the role of pan chewing in laryngeal 
carcinoma. This correlates with the finding by Sankaranarayanan et al
81
 who reported that a 
significant predisposing effect was observed of occasional pan chewing in laryngeal carcinoma. 
       Our study shows that gastro oesophageal reflux disease (GERD) is prevalent in 9% of 
benign lesions, 10% of pre malignant lesions and in 27.7% of malignant lesions. In comparison 
to the study by Galli et al 
16 
which reports 81% of patients with laryngeal carcinoma showed 
abnormal acid reflux on 24 hr pH testing, our study shows only 27.7% of patient with acid 
reflux. 
 Voice abuse is reported in 52% of benign lesions, 30% of pre malignant lesion and in 
16.6% of malignant lesion. Even though voice abuse is a well known risk factor for benign lesion 
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as reported by Swapan K Ghosh et al, 
78
 which matches with our results for benign lesions, our 
study also shows that 16.6% of patients with pre malignant lesions and 11% patients with 
carcinoma presented with voice abuse as the only risk factor. This reveals the role of voice abuse 
as a single risk factor and thus indicates the need for further studies to find out the prevalence of 
vocal abuse in pre malignant and malignant lesions. 
 Regarding the staining pattern of Lugol’s iodine, in benign lesion it stained 78% of 
lesions and remained unstained in 88.88% of malignant lesions. This matches with the 
hypothesis that “Lugol’s iodine stains the benign lesions and malignant lesions remain unstained. 
In addition to that it was noticed that after application of the dye, the lesions became well defined 
from the surrounding normal mucosa and in a few cases it was noticed that, the lesion appeared  
more extensive than prior to application of the dye. This study is first of its kind wherein the 
application of Lugol’s iodine in the diagnosis of malignant neoplasm of the vocal cords has been 
studied. It concurs with the report of its use in other UADT malignancies. 
 As per the WHO classification of pre malignant lesions of vocal cords, the six groups of 
pre malignant lesions were evaluated in our study (i.e. hyperplasia, keratosis, mild dysplasia, 
moderate dysplasia, severe dysplasia, and carcinoma insitu). As we move high in the spectrum 
from hyperplasia to carcinoma in situ, the staining pattern changes from “stains” to “unstained”. 
In hyperplasia, 22.2% cases were unstained, in keratosis, 75% of cases were unstained, in mild 
dysplasia none of the cases were unstained, in moderate dysplasia, 40% of cases were unstained, 
where as in severe dysplasia and carcinoma in situ, all the cases remained unstained after Lugol’s 
iodine application. This shows that in high risk cases i.e. severe dysplasia and carcinoma in situ, 
Lugol’s iodine is an effective tool in identifying the lesion intra operatively.  
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   In this study we found that, sensitivity of Lugol’s iodine in detecting malignant lesions is 
88.88% and sensitivity of Lugol’s iodine in detecting pre malignant lesions is       . At the 
same time the Specificity of Lugol’s iodine in detecting pre malignant or malignant lesions is 
        
   According to Lundgren and colleagues 
59
, toluidine blue can detect dysplasia or 
malignant changes with 91% sensitivity, but only 52% specificity. Comparing with this, Lugol’s 
iodine has a low sensitivity (91% Vs      ), but has a high specificity (52% Vs 78%) in 
detecting premalignant lesions. 
   In a study by Mehlmann et al, 
62
 in patients with suspected or proven laryngeal 
malignancy 5-ALA–induced fluorescence endoscopy demonstrated a sensitivity of 95% and a 
specificity of 80%, comparing to Lugol’s iodine this study has only a marginal advantage in 
sensitivity (95% Vs 88.88%) and specificity (80% Vs 78.18%). But this had disadvantages like 
Autofluorescence was unreliable when scarring was present, whereas 5-ALA–induced 
fluorescence resulted in false-positive findings in inflamed lesions
82, 63 .
 
 Even though Lugol’s iodine is a vital dye and it has been used in the lesions of the oral 
cavity, oropharynx and oesophagus, no studies have investigated its use in vocal cord lesions. 
McMahon J et al
70
 used Lugol’s iodine in the resection of oral and oropharyngeal squamous cell 
carcinoma. They suggest that Lugol’s iodine is a simple, inexpensive, and apparently effective 
means of obtaining surgical margins in the resection of oral and oropharyngeal squamous cell 
carcinoma. 
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 Massimo and colleagues
6
 have done a review of various studies on the use of Lugol’s 
iodine in oral cancer diagnosis. They found that Lugol’s iodine has a sensitivity of 0.875 and 
specificity of 0.842 in detecting oral squamous cell carcinoma. They also noted that Lugol’s 
solution has less sensitivity in identifying oral malignant and dysplastic disease but it was of 
greater specificity. Our study also detect similar findings, for malignant lesions Lugol’s iodine 
has a sensitivity of 88.88% and specificity of 78.1%,  whereas in dysplastic lesions it shows low 
sensitivity (46.67%) but high specificity (78.18%). 
 In a study by Stanford and colleagues
74
, during oesophageal endoscopy, after staining 
with Lugol’s iodine, the sensitivity of USL (Un Stained Lesions) for identifying high grade 
dysplasia or carcinoma was 96% and the specificity was 63%. They also noted that after staining 
with Lugol’s iodine the lesions were larger or more clearly defined.  Our study shows a 
sensitivity which is slightly less (88.8%), but with a high specificity (78.18%). 
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CONCLUSION 
 Lugol’s iodine is a vital dye which has been used in the lesions of the oral cavity, 
oropharynx and oesophagus. However no studies have investigated its use in vocal cord lesions. 
Our study evaluated the staining property of 1.5% of Lugol’s iodine in various vocal cord lesions 
and it analysed the efficacy of Lugol’s iodine in detecting vocal cord pre malignant and 
malignant lesions. It stains the normal mucosa and benign lesions to brown or mahogany brown 
where as malignant lesions remain unstained. In various pre malignant lesions as it goes from 
epithelial hyperplasia to carcinoma in situ in the spectrum of pre malignant lesions, the staining 
pattern changes from normally stained to unstained lesions, and in case of severe dysplasia and 
carcinoma in situ it showed 100% unstained pattern.  Lugol’s iodine has a high sensitivity (89%) 
and specificity (79%) in detecting malignant lesions. In case of pre malignant lesions it has a 
sensitivity of 47%, but specificity of 78% altogether. As this is the first study, which assesses the 
staining pattern of Lugol’s iodine in normal and diseased vocal cord, further studies are needed 
to find out its various applications including resection of vocal cord lesions and assessing the 
margin of the lesions. 
 Hence in conclusion we suggest the routine use of Lugol’s iodine as a screening tool for 
ruling out pre-malignant and malignant lesions in all suspected vocal cord lesions undergoing 
microlaryngoscopic evaluation and resection. This commonly available, inexpensive, easily 
applicable and repeatable, cost effective test would be able to detect the odd non-keratotic lesion 
as malignancy or premalignant lesion thus facilitating complete resection. 
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PATIENT’S CONSENT FORM 
 
STUDY: Diagnostic reliability of Lugol’s iodine as an adjunctive tool in the evaluation of 
laryngeal neoplasm. 
Study Number : 
Participant’s Name :                                                                                          
 Hospital number : 
Date of birth / Age : 
 
Please tick (√)  each box if you have read the study information sheet telling you about the study 
and you have understood what the doctor have told you. 
 
I have read and understood about the study [  ] 
I have been able to ask any questions [  ] 
I understand that -  I do not have to take part in the study and I can stop at any time [  ] 
I understand that - I do not have to give a reason for wanting to stop taking part [  ] 
I understand that -  if I stop participating , it will not affect my treatment [  ] 
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The doctors who are involved in the study can get information from my chart at any time for this 
study [ ] 
Later, if they need to do some more research using my data they can also get other information 
from my chart for that [  ] 
I understand that my name will be not given or shown to anybody not involved in the study [  ] 
I agree not to stop any data or results being used from this study as long as it is for scientific 
reasons [  ] 
I agree that I can take part in the above study [  ] 
 
Signature ( or thumb impression ) of the patient :                                                                Date : 
Signatory’s name                                                        : 
     
Signature of the Investigator :                                                                                                Date : 
Study investigator’s Name     : 
 
Signature of the witness        :                                                                                                  Date : 
Name of the witness              : 
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PATIENT INFORMATION SHEET 
 
You are requested to participate in this study which is aimed at finding out the effectiveness of 
Lugol’s Iodine in detecting cancer of the larynx and vocal cord polyps. In this study, you will be 
asked some questions about your disease. If you are clinically diagnosed with cancer of the voice 
box or with vocal cord polyps or with any lesions of the vocal cords, a biopsy is advised to 
confirm the diagnosis.  A microscope assisted visualization of the voice box is done and tissue is 
taken for biopsy under general anaesthesia after taking written valid consent. This is done 
routinely for all patients with similar diagnosis. During the process of taking tissue for biopsy, a 
dye named Lugol’s Iodine is applied and staining is noted for analysis.  There is no other risk 
involved in this study. Patient need not pay any extra money for the tests. This study can help in 
diagnosing and screening laryngeal cancer.  You can withdraw from this study at any moment if 
you feel so, and that in no way will compromise your treatment at ENT department. Your 
participation in the study will remain confidential and shall be known only to the investigators. 
For any queries you can contact: 
 
Dr VK Anand 
PG Registrar 
Dept. of ENT, 
CMC Vellore 
Mob: 09486840323. 
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PROFORMA 
EFFICACY OF LUGOL’S IODINE IN THE EVALUATION OF VOCAL CORD 
NEOPLASM 
Serial No.: 
Name: 
Age: 
Sex: 
Hospital number: 
Date of Admission: 
Unit: 
Duration of hoarseness: 
Any other complaints:  
( Dysphagia/ Odynophagia/ breathing difficulty/ neck swelling etc) 
Any previous treatment taken:  
(surgery/ chemotherapy/ radiotherapy) 
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Addictions: 
(smoking/ alcohol/ pan chewing/ GERD/ voice abuse) 
NPL scopy findings:  
Surgery date: 
Video recording (yes/no): 
MLscopy findings: 
Stained / unstained: 
Biopsy no. and date: 
Biopsy report: 
Final Diagnosis: 
Category:  
(1=benign, 2=pre malignant, 3=malignant, 4=bilateral lesions) 
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Data analysis sheet 
 
 
 
sernoname hospno age sex date durtnothrcmplntdysphagianeck others surgery chemo RT tobacco pan alcohol gerd voice others1nplscopy srgrydte video mlsfndngs stain biopsy report fnldgnss category
1 Goutam Bhowmick087747f 48 1 06/12/2011 6 NO NO NO NO NO NO YES YES NO NO NO 06/12/2011 NO Polypoidal unhealthy mucosa over entire superior surface of Right vocal cordNO 39237/11 mod rately differentiated sq. cell carcinomaca ci oma 3
2 Mukul Gorai 103899f 50 1 02/01/2012 2 NO NO NO N NO NO NO NO NO NO NO YES N 03/01/2012 NO Large pedunculated haemorrhagic polyp on left vocal cordYES 202/12 Papillomatous lesi n with mild epithelial atypiaBenign polyp 1
3 Gouranga Gupta059621f 50 1 04/01/2012 3 NO NO NO Nil NO NO NO NO NO NO NO YES nil right vocal cord cyst (stroboscopy)- 11-11-1104/01/2012 NO pale cyst on the right vocal cordNO 327/12 benign vocal cord polypBenign vocal cord polyp1
4 Durga prasad910646d 57 1 08/01/2012 0 NO NO NO odynophagia NO NO NO NO NO NO NO NO nil small cyst on the superior surface of left vocal cordNO Right vc keratosis; left vc cystNO 823/12 Right vc-hyperkeratosis ; left vc-acanthosisRight vc- keratosis ; left vc - cyst4
5 Gour bhandari106789f 55 1 10/01/2012 24 NO NO NO nil NO NO NO NO NO NO NO YES nil proliferative growth on ant 2/3 of left vocal cord (2-1-12)10/01/2012 NO proliferative lesion involving the anterior 2/3of left vocal cordNO 1119/12 moderately dif . sq.cell ca left vocal cordcarcinoma left glottis3
6 Uttam Pal 115347f 36 1 17/01/2012 2 NO NO NO nil NO NO NO YES NO NO NO NO nil polyp on the ant 1/3 of right vc (12/01/12)17/01/2012 NO broad based polyp on the anterior 1/3 of right vocal cordYES 1794/12 Benign vocal cord polyp rightBenign v cal cord polyp1
7 Satya narayana Kahar078064f 51 1 23/01/2012 72 NO NO NO nil NO NO NO YES YES NO NO YES nil slough covered mass on the right vocal cord (17-11-11)24/01/2012 NO Pedunculated irregular proliferative lesion on the ant 1/3 of right vocal cordYES 2713/12 benign polyp right vocal cordBenig  polyp R 1
8 Vughnuna 118473f 59 1 30/01/2012 3 NO NO NO nil NO NO NO YES NO NO NO NO nil irregular growth seen on the post 2/3of right vocal cord31/01/2012 NO congested polypoidal lesion on the middle 1/3 of left vocal cordYES 3500/12 full thickn ss dysplasia right vocal cordright voc l ord dysplasia2
9 Priyom das 805349d 22 1 06/02/2012 72 NO NO NO nil NO NO NO NO NO NO NO NO nil papilloma right vocal cord (03-02-11)06/02/2012 NO large papillomatous lesion arising from the middle 1/3 right vcYES 4233/12 laryngeal papillomaRecurrent laryngeal papilloma1
10 Dayaram Bhandari114412c 47 1 07/02/2012 3 NO NO NO nil NO NO NO NO NO NO NO YES nil left vocal cord polyp (07-02-12)08/02/2 12 YES sessile polyp arising from the middle 1/3 of left vocal cordYES 4408/12 benign polyp left vocal cordb nign polyp left vocal cord1
11 Dilip saha 092886f 54 1 07/02/2012 24 NO NO NO nil NO NO NO YES NO NO NO NO nil small keratotic spot on right vc. b/l cords congested08/02/2012 YES keratotic patch on ant 1/3 left vc. mucosal irregularity on ant 1/3 of right vcNO 4496/12 Right vc-dysplasia; left vc-marked dysplasia.ca in situcarc noma in si u 4
12 Jyoshna kundu116899f 39 2 22/02/2012 24 NO NO NO throat pain NO NO NO NO NO NO NO YES nil Rt vc-minimal oedema ; Lt-normal22/02/2012 NO irregular mucosa on middle 1/3 of b/l vocal cordsYES 6071/12 benign polyp with marked oedema consistent with ReinkesRe nkes oedema 4
13 Ajoy das 142893f 40 1 22/02/2012 12 NO NO NO globus pharyngeusNO NO NO YES NO NO NO NO nil ?keratosis ?leukoplakia b/l vocal cords (21-02-12)22/02/2012 NO ke atotic mucosa on ant 1/3 of b/l vocal cordsNO 6073/12 b/l ker tosis with mild to moderate dysplasiab lateral v cal cord keratosis4
14 Sekhar Dutta862772d 47 1 09/03/2012 6 NO NO NO nil NO NO NO NO NO NO NO NO nil 12/03/2012 NO small polyp on the right vocal cordNO 8408/12 benign polyp right vocal cordbenign polyp right vocal cord1
15 Lal bahadur prasad181037f 46 1 18/04/2012 2 NO NO NO globus pharyngeusNO NO NO NO NO NO NO NO nil polypoidal lesion on right vc (13-04-12)18/04/2012 NO nodular growth on the right vocal cord and infiltrating deep layersNO 12921/12 hyperpl sia, hyperkeratosis and moderate dysplasiaRight vocal cord dysplasi2
16 Thomas mathew201442f 50 1 11/05/2012 5 NO NO NO globus pharyngeusNO NO NO YES NO NO NO NO nil left vocal cord proliferative growth11/05/2012 NO proliferative lesion involving the anterior half of left vocal cordNO 15725/12 moderately differen iated sq.cell carcinoma left vccarci oma 3
17 Tapath kumar C201179f 33 1 15/05/2012 3 NO NO NO nil NO NO NO YES NO NO NO NO nil bilateral vocal cord keratosis (11-05-12)16/05/2012 YES keratotic patch present on bilateral cords ant2/3NO 16329/12 hyperkeratosis, epithelia hyperplasiabilateral vocal co d ker tosis2
18 Natai das 197959f 42 1 21/05/2012 36 NO NO NO occassional dyspnoeaNO NO NO YES NO NO NO NO nil small pedunculated polyp on right vocal cord (08-05-12)23/05/2012 NO polyp on the right vocal cordYES 17099/12 benign fibroepithelial polypbenign fibroe ithelial polyp1
19 Basudev Goswami199250f 63 1 21/05/2012 5 NO NO NO nil YES NO NO YES NO NO NO NO nil irregular growth involving the middle 1/3 of right vocal cord22/05/2012 NO papillomatous lesion on bilateral vc. specimen sent from bothYES 16969/12 bilateral squamous papilloma with epithelial hyperplasiabilateral squmaous papilloma4
20 kalipada das 193415f 54 1 29/05/2012 12 NO NO NO nil NO NO NO YES NO NO NO NO nil exophytic growth involving the rt vc extending into ant comm, and left vc()30/05/2012 NO ulcera ive growth involving the right vc, extending into ant comm, and left vc.NO 18020/12 mod. to poorly differenti ted sq.cell carcinomacarcinoma 4
21 Abhijith dey 202225f 27 1 03/06/2012 8 NO NO NO nil NO NO NO YES NO NO NO NO nil Pedunculated haemorrhagic polyp left vocal cord04/06/2012 NO eduncul ted haemorrhagic polyp on left vocal cordNO 18446/12 benign vocal cord polyp leftbenign vocal cord polyp left1
22 Debendra nath mahata188520f 50 1 05/06/2012 12 NO NO NO nil NO NO NO YES NO NO NO NO nil left vc heamorrhagic polyp (01-06-12)06/06/2012 NO small vocal cord polyp on the rightYES 19277/12 benign fibro epithelial polyp right vocal cordbenign polyp right vocal cord1
23 Md.ali akkas patwary216486f 58 1 06/06/2012 8 NO NO NO GERD NO NO NO YES YES NO NO NO nil growth on right vc, ant comm,  left vc keratotic area07/06/2012 NO exophytic growth on entire right cord , ant comm. and left cordNO 18987/12 mod to poorly diff. sq,c ll acarcinoma 4
24 sunny joseph090545f 47 1 10/06/2012 48 NO NO NO nil NO NO NO NO NO NO NO YES nil mucosal irregularity on the ant1/3 of left vocal cord11/06/2012 YES scarring n the medial edge of left vocal cordNO 19279/12 carcinoma in situ left vocal cordcarcinoma in situ 2
25 Sulekha parihar219989f 46 2 11/06/2012 3 NO NO NO nil NO NO NO NO NO NO NO YES nil sessile polyp at the junction of left vocal cord (09-06-12)11/06/2012 YES a br ad based haemorrhagic polyp on the left vocal cordYES 19281/12 benign vocal cord polyp leftbenign v cal cord polyp1
26 Raj kumar 659232c 48 1 12/06/2012 6 NO NO NO nil NO NO NO NO NO NO NO YES nil right vocal cord polyp (08-05-12)13/06/2012 NO pedunculated haemorrhagic polyp on right vocal cordYES 19597/12 benign fibro epithelial polypbenign polyp 1
27 Jagadish chandra debnath198061f 1 12/06/2012 NO NO NO NO NO NO NO NO NO NO NO right vocal cord polyp (8-5-12)13/06/2012 NO broad based hemorrhagic polyp right vocal cordNO 19560/12 benign vocal cord polyp rightbenign vocal cord polyp right1
28 Devanandam225257f 54 1 17/06/2012 12 NO NO NO nil NO NO NO YES NO YES NO NO nil proliferative growth on the posterior 2/3of left vocal cord18/06/2012 NO proliferative gr wth involving the entire length of left vocal cordYES 20272/12 mod.d fferentiated sq.cell ca left vocal cordc rcinoma 3
29 Thameem ansari540403c 52 1 18/06/2012 1 NO NO NO nil NO NO NO YES NO NO YES NO nil haemorrhagic polyp left vocal cord (17-05-12)19/06/2012 NO left vocal cord polypNO 20331/12 benign laryngeal nodule left vocal cordl ft vocal cord nodule1
30 Dilip Kangi 204574f 28 1 20/06/2012 6 NO NO NO nil NO NO NO NO NO NO NO NO nil left vocal cord polyp (16-05-12)21/06/2012 NO a small polyp on the left vocal cordYES 20706/12 benign laryngeal nodule left vocal cordbenign vocal nodule1
31 Banchanidhi Mohanthy199772f 51 1 20/06/2012 2 NO NO NO nil NO NO NO NO NO NO NO NO nil Right vocal cord nodule / polyp (16-0512)21/06/2012 NO bilateral vocal cord nodule , prominent on leftYES epithelial acanthosis and focal mild atypiavocal cord nodule1
32 Lakshmi 215146f 31 2 24/06/2012 36 NO NO NO nil NO NO NO NO NO NO NO NO nil right vocal cord hemorrhagic polyp (29-05-12)25/06/2012 NO a pale polyp on the right vocal cordNO 21123/12 benign vocal cord polypbenign polyp 1
33 Babu Isaac 752335b 43 1 01/07/2012 2 NO NO NO nil NO NO NO YES NO NO NO NO nil bilateral anterior 2/3rd keratosis ( 29-05-12 )NO mild irregularity of mucosa and small area of keratosis left vocal cordYES 21923/12 foc l mild dyspl sia biopsy left vocal cordmi d dysp asia 2
34 Raghu mondal2223239579f 34 1 05/07/2012 7 NO NO NO nil NO NO NO NO NO NO NO NO nil 06/07/2012 NO broad based haemorrhagic polyp at the ant.1/3 of left vocal cordYES 22560/12 fibro epithelial polypbenign left vocal cord polyp1
35 Nanni Gounder239597f 82 1 08/07/2012 6 NO YES YES bilateral ear painNO NO NO YES NO NO NO NO nil minimal congestion and irregularity on the ant.1/3 right vc09/07/2012 YES ulceroproliferative growth involving the ant1/3 of right cord and ant.commissureNO 22807/12 mod. differentiated squamous cell car ino ac rcinoma gl ttis 3
36 suresh 199186f 29 1 10/07/2012 3 YES NO NO nil NO NO NO NO NO NO NO NO nil broad based haemorrhagic polyp middle 1/3 Lt.cord (strobo 9/5/12)10/07/2012 NO broad based haemorrhagic polyp at the jn. of ant1/3 & post2/3 Lt.vocal cordNO 23103/12 benign fibro epithelial polyp, biopsy Left vocal cord.be ign fibr  e ithelial polyp left vocal cord1
37 subrato ghosh241450f 46 1 10/07/2012 5 NO NO NO haemoptysis NO NO NO YES NO NO NO NO nil small polyp with whitish patch in it on Rt.vocal cord(6/7/12)11/07/2012 YES polyp arising at the jn. of ant1/3 and post2/3 right vocal cordYES 23148/12 be ign fibro epithelial polypbenign polyp Right polyp1
38 Sumitra devi 244908f 38 2 11/07/2012 12 NO NO NO nil NO NO NO NO NO NO NO YES nil right vocal cord haemorrhagic polyp (11/7/12)NO polyp on the medial aspect of right vocal cordYES 23299/12 benign fibr  epithelial polyp biopsy right vocal cordbenign polyp right vocal cord.1
39 MOHD.LIAKATH ALI071427F 57 3 31/05/2012 12 NO NO NO N NO NO NO NO NO NO NO NO N 30/04/12 - RIGHT MONOCORDITIS01/06/2012 NO THICKENED AND FRIABLE MUCOSA RIGHT CORDNO 18216/12 SQUAMOUS CELL CARCINOMA RIGHT VOCAL CORDCARCINOMA RIGHT VOCAL CORD3  
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40 DIPANKAR ROY221623F 59 1 18/06/2012 8 NO NO NO N NO NO NO YES NO NO YES NO N LEFT MONOCORDITIS ( 11/06/12)19/06/2012 NO FIRM IRREGULAR LESION ANT 1/3 OF B/L VOCAL CORDSNO 20329/12 MODERATE DYSPLASIA LEFT VOCAL CORDM DERATE DYSPLASI  EFT VOCAL CORD2
41 Rama swamy237008f 59 1 05/07/2012 36 NO NO NO N NO NO NO YES NO NO NO NO N IRREGULARITY OF ANT 1/3 LEFT VOCAL CORD (30/06/12)06/07/2012 NO IRREGULARITY ANT 1/2 RIGHT VOCAL CORD; LEUKOPLAKIA ANT 1/3 LEFT VOCAL CORDNO 2256 /12 SQUAMOUS CELL CARCINOMA RIGHT VOCAL C RDCARCINOMA RIGHT VOCAL CORD3
42 DILIP MONDAL238398F 50 1 12/07/2012 5 NO NO NO N NO NO NO NO NO NO NO YES N POLYP ON THE RIGHT VOCAL CORD13/07/2012 NO SMALL HAEMORRHAGIC POLYP ON THE RIGHT VOCAL CORDYES 23483/12 MILD EPITHEALIAL DYSP ASIA RIGHT VOCAL CORDM D DYSPLASIA IGHT VOCAL CORD2
43 SAMAR MONDAL249546F 52 1 17/07/2012 4 YES NO NO THROAT PAINO NO NO YES NO NO NO NO N PROLIFERATIVE GROWTH LEFT VOCAL CORD (17/07/12)18/07/2012 NO INFILTRATIVE GROWTH LEFT VOCAL CORDNO 24171/12 SQUAMOUS CELL CARCINOMA LEFT VOCAL CORDCARCINOMA LEFT VOCAL CORD3
44 PRANAYESH MONDAL198961F 57 1 01/08/2012 6 NO NO NO N NO NO NO YES NO NO NO NO N BILATERAL THICKENED VOCAL CORD WITH IRREGULAR MARGIN (02/06/12)02/08/2012 NO BILATERAL TH CK NED VOC L CORDSYES 26029/12 MI D DYSPLASIA LEFT VOCAL CORDMILD DYSPLASI  EFT VOCAL CORD2
45 BIVAS JANA250542F 46 1 02/08/2012 6 NO NO NO N NO NO NO YES NO YES NO NO N RIGHT VOCAL CORD POLYP (2/7/12)03/08/2012 NO POLYPS ON BILATERAL VOCAL CORDSYES 26274/12 BI ATERAL BENIGN VOCAL CORD POLYPILATERAL BENIGN VOCAL CORD POLYP4
46 NIRMAL SAPKOTA257819F 48 1 02/08/2012 12 YES YES NO N NO NO NO YES NO YES NO NO N PROLIFERATIVE GROWTH ON RIGHT WITH SUB GLOTTIC EXTN. (2/8/12)07/08/2012 NO PROLIFERATIVE GROW H INVOLVING B/L VOCAL CORDS WITH SUB GLOTTIC EXTNNO 26706/12 SQUAMOUS CELL CARCINOMA LARYNXCAR INOMA GLOTTIS3
47 UTPAL SAHA250494F 35 1 03/08/2012 18 NO NO NO N NO NO NO YES NO NO NO YES N RIGHT VOCAL CORD POLYP (18/07/12)03/08/2012 NO BROAD BASED POLYP ON RIGHT VOCAL CORDYES 26292/12 BENIGN PO YP IGHT VOCAL CORDBENIGN POLYP RIGHT VOCAL CORD1
48 NEPAL BHUNIA228288F 34 1 05/08/2012 6 NO NO NO N NO NO NO NO NO NO NO YES N RIGHT VOCAL CORD POLYP (20/6/12)06/08/2012 NO SMALL POLYP ON THE RIGHT VOCAL CORDES 26382/12 BENIGN VOCAL CORD POLYP RIGHT SIDEBENIGN POLYP RIGHT VOCAL CORD1
49 ROY OOMMEN262951F 53 1 07/08/2012 5 NO NO NO N NO NO NO YES NO YES NO NO N WHITE IRREGULAR LESION ON POST 1/3 LEFT VOCAL CORD (7/8/12)09/08/2012 NO WHITE PATCH N TED ON BILATERAL VOCAL CORDYES 26992/12 MODERATE DYSPLASIA BILATERAL VOCAL CORDMODERATE DYSPLASIA BILATERAL VOCAL CORD4
50 SHANMUGHAM A N251563F 80 1 08/08/2012 1 NO NO NO N NO NO NO NO NO NO NO NO N IRREGULARITY ON RIGHT VOCAL CORD (21/07/12)09/08/2012 NO KERATOTIC GROWTH ON POST 2/3 OF RIGHT VOCAL CORDYES 26892/12 SQUAMOUS CELL CARCIN MA RIGHT VOCAL CORDSQUAMOUS ELL CARCINOMA RIGHT VOCAL CORD3
51 ABU CHATTER GAZI230236F 56 1 09/08/2012 3 NO NO NO GLOBUS PHARYNGEUSNO NO NO NO NO NO NO YES N LEFT VOCAL CORD POLYP (28/06/12)10/08/2012 NO PALE POLYP ON LEFT VOCAL CORDN 27148/12 BENIGN POLYP LEFT VOCAL CORDBENIGN POLYP EFT VOCAL CORD1
52 SUMANT KUMAR MONDAL248419F 42 1 10/08/2012 12 NO NO NO N NO NO NO NO NO NO NO YES N PAPILLOMA/POLYP OF LEFT VOCAL CORD (14/7/12)10/08/2012 NO BROAD BASED POLYP ON THE ANT 1/3 OF LEFT VOCAL CORDYES 27158/12 BENIGN VOCA  CORD POLYP LEFT VOCAL CORDLEFT VOCAL CORD BENIGN POLYP1
53 SONY BURMAN922975D 35 1 10/08/2012 3 NO NO NO N NO NO NO NO NO NO NO NO N LEFT VOCAL CORD HAEMORRHAGIC POLYP (8/8/12)10/08/2012 NO EMORRHAGIC POLYP ON THE ANT 1/3 OF LEFT VOCAL CORDNO 27154/12 BENIG  VOCAL CORD P LYP LEFTBENIGN POLYP LEFT VOCAL CORD1
54 MALATHY 070001C 31 2 10/08/2012 4 NO NO NO N NO NO NO NO NO NO NO YES N LEFT VOCAL CORD HAEMORRHAGIC POLYP (14/7/12)10/08/2012 NO PALE POLYP ON THE LEFT VOCAL CORDES 27156/12 BENIGN VOCAL CORD P0LYP LEFTBENIGN POLYP LEFT VOCAL CORD1
55 BIJALI BALA DAS261200F 62 2 12/08/2012 36 NO YES NO N NO NO NO NO YES NO NO NO N ULCERATIVE LESION ON THE RIGHT VOCAL CORD (31/7/12)13/08/2012 NO ENTIRE LENGTH OF RIGHT VOCAL CORD THICKENED AND CONGESTEDNO 27287/12 CARCINOMA IN SITU RIGHT VOCAL CORCAR NOMA I  SITU RIGH  VOCAL CORD3
56 SANJOY DEY177026F 36 1 22/08/2012 72 NO NO NO N NO NO NO NO NO NO YES YES N KERATOSIS RIGHT VOCAL CORD (22/8/12)23/08/2012 NO KERATOTIC NODULE ON RIGHT VC & SMALL NODULE ON LEFT VCYES 28654/12 BILATERAL BENIGN VOCAL CORD POLYPE I  POLYP BILATERA  VOCAL CORD4
57 HARADSHAN KONGER276257F 62 1 23/08/2012 3 NO NO NO N NO NO NO YES NO NO NO YES N PROLIFERATIVE GROWTH ON RIGHT VOCAL CORD (23/8/12)24/08/2012 NO PROLIFERATIVE LESION ON THE RIGHT VOCAL CORDNO 2881 12 MOD.DIFF. SQU MOUS CELL CARCINOMA RIGHT VOCAL CORDCARCIN MA RIGHT VOCAL CO D.3
58 MAHADEV PAL255602F 61 1 26/08/2012 2 NO NO NO N NO NO NO NO NO NO NO YES N RIGHT VOCAL CORD GROWTH (26/8/12)27/08/2012 NO POLYPOIDAL MASS ON THE RIGHT VOCAL CORDYES 29008/12 EPITHELIAL HYPE PLASIA RIGHT VOCAL CORDEPITHELIAL HYPERPLASIA RIGHT VOCAL CORD2
59 Tapas Kumar Das281656f 30 1 29/08/2012 2 NO NO NO n NO NO NO NO NO NO NO YES n polyp on the left vocal cord30/08/2012 NO haemorrhagic polyp on the left vocal cordYES 29544/12 epithelial hyperplasia left vocal cordEpithelia  hyperplasia left vocal cord2
60 Biswanath Paul267921f 44 1 30/08/2012 4 NO NO NO n NO NO NO NO NO NO NO NO n polyp on the right vocal cord31/08/2012 NO Haemorrhagic polyp on the right vocal cordYES 29616/12 benign v cal cord polyp rightBenign polyp right vocal cord1
61 Prasanjith Chakraborty282510f 36 1 30/08/2012 4 NO NO NO n NO NO NO YES YES YES NO YES n Hemorrhagic polyp left vocal cord31/08/2012 NO Large hemorrhagic polyp on left vocal cordYES 29620/12 benign vocal cord polyp leftBenign polyp left vocal cord1
62 Om Prakash Nonia256097f 39 1 31/08/2012 48 NO NO NO n NO NO NO NO YES NO NO NO n Right vocal cord polyp (28/8/12)31/08/201 NO cystic lesion on the middle 1/3 of right vocal cordYES 29709/ 2 Right vocal cord epithelial hyperplasiaEpithelial hyperplasia right vocal cord2
63 Subrata banik276927f 28 1 31/08/2012 9 NO NO NO n NO NO NO YES NO YES NO NO n left vocal cord polyp (22/8/12)31/08/2012 YES large polyp arising from the left vocal cordYES 29702/12 benign vocal cord polyp left sideBenign polyp left vocal cord1
64 Purushotham R908679c 49 1 04/09/2012 1 NO NO NO n NO NO NO NO NO NO NO YES n Right vocal cord polyp (17/8/12)05/09/2012 NO angiomatous polyp on the right vocal cordNO 30127/12 benign vocal cord polyp rightBenign polyp right vocal cord1
65 sujay sardar 282594f 52 1 04/09/2012 6 NO NO NO n NO NO NO YES NO NO NO NO n Irregular growth on right vocal cord, ant commissure.05/09/2012 NO ulceroproliferative growth on the right vocal cord & right ventricleNO 30233/12 mod.diff.squamous cell carci oma right vocal cordcarcinoma right voc l cord3
66 Bidhun Ranjan Roy274334f 51 1 06/09/2012 12 NO NO NO n NO NO NO NO NO NO NO NO n irregularity right vocal cord07/09/2012 NO haemorrhagic polyp RT.vc.  &   Small polyp LT.vcYES 30358/12 benign polyp Right & left vocal cordBenign polyp bil teral vocal cord4
67 Bablu Hait 289934f 35 1 06/09/2012 3 NO NO NO globus pharyngeusNO NO NO YES YES YES NO YES n Right vocal cord polyp (6/9/12)07/09/2012 NO pale polyp on the right vocal cordYES 30482/12 benign vocal cord polyp rightBenign polyp right vocal cord1
68 Mukul Saha 281861f 45 1 07/09/2012 12 NO NO NO globus pharyngeusNO NO NO NO NO NO NO YES n left vocal cord polyp (29/8/12)07/09/2012 NO hemorrhagic polyp on the left vocal cordYES 30573/12 benign vocal cord polyp leftBenign polyp left vocal cord1
69 Sanatan Naskar260067f 58 1 07/09/2012 18 NO NO NO n NO NO NO NO NO NO NO YES n left vocal cord polyp (3/9/12)07/09/2012 NO reddish polypoidal lesion on the left vocal cordYES 30579/12 vocal cord p lyp with hemorrhage left sideBenign polyp left vocal cor1
70 Venkata Rama Reddy627327c 57 1 12/09/2012 1 NO NO NO n NO NO NO NO YES YES NO NO N polyp on right vocal cord13/09/2012 NO small polyp on right vocal cordYES 31292/12 right vocal cord polyp with epithelial hyperplasiaEpithelial hyper lasia right vocal cord2
71 Sk.Abdul hasem294002f 52 1 12/09/2012 36 NO NO NO n NO NO NO YES NO NO NO NO n proliferative growth involving right vc and right NO cord12/09/2012 NO ulceroproliferative growth on rigth vocal cord and right NO cordNO 31133/12 squamous cell carcinoma vo al cordscarcinoma glottis 3
72 Md.Mehabub ali278466f 45 1 16/09/2012 2 NO NO NO n NO NO NO NO NO NO NO YES n left vocal cord polyp17/09/2012 NO pale polyp on the left vocal cordYES 31713/12 left vocal cord polyp with mild dysplasiaMild dysplasia eft vocal cord2
73 Ebrahim sk 293742f 33 1 18/09/2012 3 NO NO NO globus pharyngeusNO NO NO YES NO NO NO NO n bilateral vocal cord lesion (10/9/12)18/09/2012 NO polyp on RT.vc & papillamatous lesion on left Vc.YES 31744/12 benign haemorrhagic polyp right & left vocal cordBenign polyp bilateral vocal cords4
74 Niranjan Das253527f 54 1 18/09/2012 18 NO NO NO globus pharyngeusNO NO NO NO NO NO YES YES n ?left vocal cord keratosis (17/9/12)18/09/2012 NO whitish patch on the left vocal cordYES 31741/12 left vocal cord biopsy - no evidence of malignancyBenign polyp left vo al cord1
75 Sabu Mathew300270f 29 1 18/09/2012 3 NO NO NO n NO NO NO NO NO NO NO YES n left vocal cord polyp ( 17/9/12)18/09/20 2 NO haemorrhagic polyp on left vocal cordYES 31906/12 benign haemorrhagic polyp left vocal cordBenign polyp left vocal cord1
76 Bankim Bihari Kar302240f 58 1 19/09/2012 6 NO NO NO n NO NO NO YES NO NO NO NO n white irregular lesion on left vocal cord19/09/2012 NO whitish patch on left vocal cordNO 31955/12 early invasive sq.cell carcinoma left vocal cordCarcinom  left vocal cord3
77 Sanjeet Rout289432f 39 1 19/09/2012 7 NO NO NO n NO NO NO NO NO NO NO NO n pedunculated polyp with left vocal cord (11/9/12)19/09/2012 NO large friable polyp on left vocal cordYES 31953/12 benign polyp left vocal cordB nign polyp left vocal cord1
78 sanjoy Dutta245466f 50 1 26/09/2012 18 NO NO NO n NO NO NO YES YES YES NO NO n keratosis Right vocal cord (18/7/12)27/09/2012 NO keratotic lesion on the right vocal cordYES 33182/12 biopsy from right vocal cord with moderate dysplasiaModerate dysplasia right vocal cord2
79 Tapan kumar pauli307133f 39 1 27/09/2012 18 NO NO NO n NO NO NO YES NO NO NO NO n polypoidal growth on right vocal cord (24/9/12)28/09/2012 NO large haemorrhagic polyp on the right vocal cordYES p thelial hyperplasia right vocal cordEpithelial hyperpl sia - Right vocal cord2
80 kannan 299960f 65 1 27/09/2012 2 NO NO NO n NO NO NO NO NO NO NO YES n proliferative lesion on right vocal cord (19/9/12)27/09/2012 NO keratotic lesion right vocal cordNO 33093/12 mod.diff.sq.cell carcinoma right vocal cordCarcinoma right vocal cord3
81 Hemanta Mondal293295f 36 1 28/09/2012 18 NO NO NO n NO NO NO YES YES YES NO NO n sessile polyp on right vocal cord28/09/2012 NO bilobed pedunculated polyp on right vocal cordNO 33351/12 benign polyp right vocal cordBenign polyp right vocal cord1
82 Jeeva 300992f 26 2 01/10/2012 6 NO NO NO n NO NO NO NO NO NO NO YES n right VC-growth; left VC-polypoidal change02/10/2012 NO proliferative lesion right VC; polypoidal lesion left VCNO 33664/12 right and left vocal cord carcinoma in situCarcinoma in situ bil teral vocal cord4
83 Jayanta Choudhurie315341f 31 1 09/10/2012 3 NO NO NO n NO NO NO YES NO NO NO NO n right vocal cord keratosis (8/10/12)09/10/2012 NO whitish lesion on the ant 1/2 of right vocal cordNO 3475 12 mild epithelial hyperplasia right vocal cordEpith lia  hyperplasia right vocal cord2
84 Ramapada Mahapatra315893f 40 1 09/10/2012 3 NO NO NO n NO NO NO NO YES NO NO YES n polypoidal lesion right vocal cord (8/10/12)09/10/2012 NO a pedunculated irregular surfaced polyp on right vocal cordYES 34743/12 benign v cal cord polyp right sideBenign polyp right vocal cord1
85 Santhi Pal 272816f 38 1 09/10/2012 48 NO NO NO n NO NO NO NO NO NO NO YES n right vocal cord polyp (27/8/12)09/10/2012 NO congested polyp right vocal cordYES 34575/12 benign vocal cord polyp right sideBenign polyp right vocal cord1
86 Kripa Sindhu Das284974f 42 1 09/10/2012 8 NO NO NO n NO NO NO YES NO NO NO YES n right vocal cord polyp with keratosis09/10/2012 NO right vocal cord polypYES 34579/12 acanthosis with no evidence of dysplasiaBenign polyp right vocal cord1
87 Dinesh Sil 314362f 49 1 14/10/2012 24 NO NO NO n NO NO NO NO NO NO NO YES n irregular mass on the right vocal cord15/10/2012 NO broad based polyp on the anterior 1/3 of right vocal cordYES 35375/12 benign vocal cord polyp right sideBenign p lyp right vocal cord1
88 Iruday Doss 326396f 47 1 01/11/2012 6 NO NO NO n NO NO NO NO YES YES NO NO n growth on left vocal cord (22/10/12)02/11/2012 NO keratotic patch on left VC & broad based polyp on Right VCNO 37721/12 Rt-benign polyp ; Lt-epithelial hyperplasiaRt.VC-B n gn polyp ; Lt.VC - Epithelial hyperplasia4
89 Badarul Islam231342f 33 1 12/11/2012 96 NO NO NO globus pharyngeusNO NO NO YES NO NO NO YES n keratosis left vocal cord13/11/2012 NO pale polyp with keratotic surface on left vocal cordYES 39002/12 benign vocal cord polyp leftBenign polyp left vocal cord1
  
94 
 
 
COLOUR PLATES 
 
 
 
 
Colour plate. 1 Benign lesion on right vocal cord 
 
 
 
 
Colour plate. 2  Wiping of the vocal cord with dry cotton ball 
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Colour plate. 3  Applying Lugol’s iodine on the vocal cords 
 
 
 
 
 
Colour plate. 4  Uniform staining of the benign lesion and vocal cords  
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Colour plate. 5  High grade dysplasia on the right vocal cord 
 
 
 
 
Colour plate. 6  Application of the Lugol’s iodine on high grade dysplasia 
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Colour plate. 7  Immediately after the application of Lugol’s iodine on high grade dysplasia 
 
 
 
 
Colour plate. 8  Differential staining after 1 minute showing well defined lesion with clear 
margin of a high grade dysplasia 
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Colour plate. 9  Operating room set up during ML scopy. 
 
 
 
 
